%PDF-1.3
%
6 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
x10Dާ2)K=J8/ Hc4sJnV%2=kE^ca%c-adAΙ>1ҧ\Îk6^V6CyH'~.ڂ'2
endstream
endobj
10 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2021-03-02T09:34:50-08:00
2021-02-12T18:30:10+05:30
application/pdf
LRB-2020-0022-ver9-Chang_3P 4..10
uuid:c359d513-88fc-4c80-ad2e-c29f0e10619b
uuid:85c40fe7-224e-4e11-a155-53a175986238
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
26 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(and)-338.5(primary)-332.7(care)-336.2(physicians)-335.8(to)-336.4(readily)-332.8(identify)-338.6(knowledge-)]TJ
0 -1.1174 TD
[(able)-358.2(LD)-349.8(caretakers,)-360(\(2\))-354.6(recognize)-354.5(health)-354.8(care)-359.2(professionals)]TJ
0 -1.1116 TD
[(and)-378.8(organizations)-386.6(efciently)-377.6(serving)-383.2(LD)-378.6(patients,)-383.4(\(3\))-377.6(raise)]TJ
T*
[(awareness)-308.8(of)-301.7(LDs)-298.9(within)-301.6(physician)-306.1(and)-298.2(patient)-304.2(populations,)]TJ
T*
[(and)-321.2(\(4\))-325.8(encourage)-319.8(health)-326(care)-324.6(institutions)-324.6(to)-319.1(aspire)-319.9(to)-324.9(serve)]TJ
0 -1.1174 TD
[(lymphatic)-336.4(patients)-333.9(optimally.)-338.8(Herein,)-330.1(we)-332.5(describe)-340.5(the)-332.9(steps)]TJ
0 -1.1116 TD
[(taken)-342(to)-336.4(establish)-334.8(standards)-340.3(for)-337.3(LE&RN)-339.3(COEs)-335.6(in)-336.4(the)-338.7(diag-)]TJ
T*
[(nosis)-281.7(and)-280.9(treatment)-285.7(of)-284.4(LDs.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 626.4565 Tm
[(The)-338.2(StartRecognizing)-337.3(the)-334.7(Need)-333.4(for)-330.9(COEs)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 610.0156 Tm
[(Deluged)-201.1(with)-207.1(phone)-196.7(calls)-203.7(and)-200.3(emails)-206.1(from)-201.4(patients)-201.4(seeking)]TJ
-1.0137 -1.1116 TD
[(diagnosis)-281.7(and)-275.2(care)-278.6(for)-279.7(LDs,)-273.6(leadership)-279.5(at)-280(LE&RN)-276(identied)]TJ
T*
[(the)-419.3(need)-421.4(for)-412.2(COEs.)-419.7(LE&RN)-420(was)-419.8(already)-420.2(requiring)-420.2(newly)]TJ
0 -1.1174 TD
[(established)-269(chapters)-265.6(to)-261.5(identify)-263.8(LD)-263.4(health)-262.6(care)-267(professionals)]TJ
0 -1.1116 TD
.0246 Tc
[(a)24.6(n)24.6(d)-527(ins)-5.1(titut)-5.4(i).3(ons)-552.3(within)-552.5(thei)-5.4(r)-546.7(g).5(eo)-5.3(graphi)-5.4(cal)-546.8(ar)-5.3(eas;)-552.6(how-)]TJ
T*
[(e)-6.6(v).4(er,)-301.5(s).6(imp)-5.4(l).2(y)-299.1(l).2(i)-5.5(s).6(ting)-304.9(t).2(hese)-306.1(reso)-5.4(urces)-304.7(on)-299.1(a)-306.1(w)-.5(ebsit)-5.5(e)-300.3(was)-304.7(not)]TJ
T*
0 Tc
[(deemed)-345.4(the)-332.9(ideal)-342.2(way)-339.4(to)-336.4(guide)-340.9(patients)-339.6(to)-336.4(the)-338.7(best)-339.6(care)-336.2(for)]TJ
0 -1.1174 TD
[(several)-287.6(reasons.)]TJ
1.0137 -1.1116 TD
.0187 Tc
[(Ly)-5.4(mpha)-6.6(tic)-334.9(kno)-5.4(wle)-6.6(dge)-334.9(is)-333.5(of)-5.4(f)-327.9(t)-5.6(he)-334.9(rad)-5.4(a)-.8(r)-333.7(f).4(or)-333.7(man)-5.4(y)-328(p)-5.4(hys)-5.2(i-)]TJ
-1.0137 -1.1116 TD
.02 Tc
[(c)-5.3(i)1.5(ans)-349.5(g)1.6(iven)-349.7(that)-344.1(m)-5.4(e).5(dic)-5.3(a).5(l)-349.8(s)1.8(chool)-349.8(education)-349.7(o)1.6(n)-349.7(l)1.5(ymphatics)]TJ
0 -1.1174 TD
[(a)-5.2(v)1.7(erages)]TJ
/F9 1 Tf
4.1643 0 TD
0 Tc
(<)Tj
/F5 1 Tf
.5702 0 TD
.0188 Tc
[(30)-494.9(min)-5.3(u).4(tes)-5.1(.)]TJ
7.3823 0 0 6.5614 156.7559 504.7935 Tm
.0222 Tc
(10)Tj
9.843 0 0 9.843 169.3417 500.4282 Tm
.0188 Tc
[(U)-6.2(n).4(fam)-6.6(ili)-5.5(arit)-5.5(y)-489.1(w)-.4(i)-5.5(t).3(h)-494.9(l).3(ymp)-5.3(h).4(ati)-5.5(c)-.7(s)]TJ
-11.1335 -1.1116 TD
[(m)-6.7(a)-.8(kes)-379.6(i).2(t)-379.9(d).3(if)-5.4(cu)-5.4(l).2(t)-374.2(f)-5.4(or)-379.8(many)-379.8(phy)-5.4(sic)-6.6(i).2(an)-5.4(s)-373.9(t).2(o)-379.8(c)-.8(o)-5.4(rrec)-6.6(tly)-379.8(dia)-6.6(g).3(-)]TJ
T*
[(n)-5.3(o).4(se)-306(LD)-6.2(.)-301.4(D)-.4(i)-5.5(a)-.7(gno)-5.3(sis)-304.6(a)-6.5(nd)-304.8(tre)-6.5(a)-.7(tmen)-5.3(t)-305(o).4(f)-304.8(L)-.8(Ds)-304.6(ca)-6.5(n)-299.1(b)-5.3(e)-300.2(c)-6.5(ompl)-5.5(i-)]TJ
0 -1.1174 TD
.0186 Tc
[(c)-6.7(a)-.9(ted)-230.2(a)-.9(n)-5.5(d)-224.4(ca)-6.7(n)-224.4(r)-5.5(equi)-5.7(re)-231.3(vis)-5.3(iti)-5.7(ng)-224.4(d)-5.5(i).1(ff)-5.5(ere)-6.7(n).2(t)-230.3(t).1(ype)-6.7(s)-224.2(o)-5.5(f)-224.4(p)-5.5(hys)-5.3(icia)-6.7(ns)]TJ
0 -1.1116 TD
.021 Tc
[(a)-4.3(n)2.6(d)-291.1(o)2.6(ther)-291.1(health)-291.1(profession)]TJ
11.4964 0 TD
.0188 Tc
[(al)-5.5(s.)-295.7(Simp)-5.3(ly)-293.3(kn)-5.3(owin)-5.3(g)-293.3(t).3(he)-294.5(n)-5.3(a)-.7(me)]TJ
-11.4964 -1.1116 TD
[(o)-5.4(f)-374(a)-375.2(l).2(ymp)-5.4(h).3(at)-5.6(ic)-375.2(phy)-5.4(sic)-6.6(i).2(an)-374.1(c)-6.6(a)-.8(n)-374.1(b).3(e)-375.2(i).2(n)-5.4(s).5(uf)-5.4(ci)-5.6(e)-.8(nt)-374.2(in)-5.4(for)-5.4(m)-.9(ati)-5.6(o).3(n)]TJ
T*
[(f)-5.4(o).3(r)-310.7(m)-.9(os)-5.2(t)-305.1(p)-5.4(ati)-5.6(e)-.8(nts)-5.2(.)-307.3(Fo)-5.4(r)-304.9(e)-6.6(xamp)-5.4(le,)-313(a)-.8(fte)-6.6(r)-304.9(d)-5.4(i).2(ag)-5.4(nos)-5.2(is,)-313(s).5(ta)-6.6(ndar)-5.4(d).3(-)]TJ
0 -1.1174 TD
.0186 Tc
[(o)-5.5(f-c)-6.7(are)-398.4(t).1(re)-6.7(atme)-6.7(nt)-391.6(f)-5.5(o).2(r)-391.4(L)-6.7(E)-392.6(r).3(e)-6.7(qui)-5.7(res)-397(m)-1(ult)-5.7(i).1(pl)-5.7(e)-392.6(v).2(i)-5.7(s).4(it)-5.7(s)-391.2(t)-5.7(o)-391.4(s).4(p)-5.5(e)-.9(-)]TJ
0 -1.1116 TD
.0188 Tc
[(c)-6.5(i).3(al)-5.5(ly)-414.3(t)-5.5(r).5(ai)-5.5(ned,)-416.6(c)-6.5(e)-.7(rt)-5.5(ie)-6.5(d)-414.3(ly)-5.3(mphe)-6.5(dema)-421.2(the)-6.5(r).5(ap)-5.3(ist)-5.5(s)-414.1(fo)-5.3(r)-414.2(c)-6.5(om-)]TJ
T*
.0205 Tc
[(plete)-684.4(d)-3.6(econgestive)-684.4(t)-3.8(herapy)-689(\()7.9(C)12.6(D)7(T)12.5(\))7.9()12.6(m)6.7(a)12.5(n)7.9(u)13.6(a)6.7(l)-677.6(l)13.5(y)7.9(m)12.4(p)7.9(h)13.6(a)6.7(t)7.8(i)13.5(c)]TJ
0 -1.1174 TD
.0122 Tc
[(drain)5.3(ag)5.3(e)-220.4(\()-86.8(MLD\),)-215.9()-.3(tt)5.2(in)5.3(g)-225(o)5.3(f)-219.3(c)-1.6(o)5.3(m)-1.6(p)5.3(r)-.4(es)5.5(si)5.2(on)-219.3(garmen)5.3(ts,)-215.9(s)-.2(ki)5.2(n)-225(c)4.2(ar)5.4(e)]TJ
0 -1.1116 TD
.0099 Tc
[(e)-3.9(d)3(uc)-3.9(ation,)-304.5(a)-3.9(n)3(d)-302.2(s)-2.5(om)-3.9(etimes)-307.8(training)-302.2(in)-308(the)-303.4(u)3(se)-303.4(of)-302.2(pneuma)-3.9(tic)]TJ
T*
.0123 Tc
[(co)5.4(mp)5.4(res)5.6(s)-.1(i)5.3(o)-.3(n)-605.1(t)-.4(h)5.4(e)-1.5(r)5.5(a)-1.5(py)5.4(.)-607.4(O)4.6(ften,)-607.4(p)5.4(at)5.3(ient)5.3(s)-610.6(n)5.4(eed)-610.8(t)5.3(rain)5.4(ing)-605.1(f)5.5(or)]TJ
0 -1.1174 TD
.013 Tc
[(hom)4.9(e)5(/).3(se)5(lf)6.2(-c)5(are)-421.2(o)6.1(f)-425.8(L)5(E)-427(b)6.1(ec)5(au)6.1(se)-421.2(ML)5(D)-420.9(i).3(s)-419.9(e)-.8(x)6.1(p).4(en)6.1(si)6(ve)5(,)-422.4(i).3(n)6.1(a)-.8(d)6.1(e)-.8(-)]TJ
0 -1.1116 TD
.0121 Tc
[(quately)-265.5(cov)5.2(e)-1.7(r)5.3(e)-1.7(d)-265.5(b)-.5(y)-271.2(m)4(ed)5.2(ical)-271.4(i)5.1(n)-.5(s)]TJ
12.8384 0 TD
.0118 Tc
[(urers)5.1(,)-273.9(a)3.8(nd)-271.5(o)4.9(f)-.8(t)4.8(e)-2(n)-271.5(u)4.9(navail)4.8(abl)4.8(e)]TJ
-12.8384 -1.1116 TD
.0125 Tc
[(out)5.5(si)5.5(de)-208.6(larg)5.6(e)-214.4(m)4.4(et)5.5(ro)5.6(pol)5.5(it)5.5(an)-207.5(ar)5.7(eas.)-209.8(If)-207.4(st)5.5(an)5.6(dard)-207.5(CDT)-214.4(c)4.5(ar)5.7(e)-214.4(f)5.7(ai)5.5(ls)5.8(,)]TJ
0 -1.1174 TD
.0122 Tc
[(patient)5.2(s)-656.8(m)4.1(ay)-651.3(op)5.3(t)-651.4(for)-651.2(ly)5.3(mp)5.3(hati)5.2(c-s)5.5(p)-.4(ari)5.2(n)-.4(g)-651.3(lip)5.3(os)5.5(uctio)5.3(n)-651.3(o)-.4(r)]TJ
0 -1.1116 TD
.0118 Tc
[(lymp)4.9(hat)4.8(i)-.9(c)-566.4(m)-2(i)4.8(c)-2(ro)4.9(su)4.9(rgeri)4.8(es)5.1(,)-573.4(w)4.1(hich)-571(i)4.8(n)-.8(cl)4.8(ud)4.9(e)-572.2(l)-.9(y)4.9(m)-2(p)4.9(h)-.8(o)4.9(v)-.8(eno)4.9(u)-.8(s)]TJ
T*
.0094 Tc
[(bypa)-4.4(s)2.7(s)-740.3(\()-3.2(LV)-4.1(B)-4.2(\))-740.4(and)-740.5(v)2.5(a)-4.4(s)-3(cula)-4.4(rize)-4.4(d)-740.5(l)-3.3(ym)-4.4(ph)-740.5(node)-741.6(tra)-4.4(n)2.5(sfer)]TJ
T*
.012 Tc
[(\(VLNT\))-236.7(pr)5.2(oced)5.1(ures.)-233.3(Th)5.1(e)-237.9(s)-.4(ur)5.2(geon)5.1(s)-242.3(p)5.1(ro)5.1(vid)5.1(i)-.7(n)5.1(g)-236.8(th)5.1(ese)-237.9(i)5(nt)5(ricat)5(e)]TJ
0 -1.1174 TD
[(pro)5.2(cedu)5.2(res)-357.4(a)-1.7(r)5.3(e)-358.8(hi)5.1(ghl)5.1(y)-357.6(t)-.6(r)5.3(a)-1.7(i)5.1(n)-.5(ed)-357.6(an)5.2(d)-357.6(s)-.3(h)5.2(o)-.5(u)5.2(l)-.6(d)-357.6(p)5.2(erf)5.3(o)-.5(r)5.3(m)-358.8(a)-358.8(m)4(in)5.2(i-)]TJ
0 -1.1116 TD
.0117 Tc
[(mu)4.8(m)-474.4(n)4.8(umber)-473.2(o)-.9(f)-473.2(s)5(ur)4.9(ger)4.9(i)-1(es)-473(per)-473.2(y)4.8(ear)-467.4(to)-473.2(mai)4.7(n)-.9(t)4.7(a)-2.1(i)4.7(n)-473.2(su)4.8(rg)4.8(ical)]TJ
T*
.0112 Tc
[(ski)4.2(l)-1.5(l)4.2(s)-1.2(.)-366.6(L)3.2(E)-365.5(m)-2.6(ay)-364.3(have)-365.4(geneti)4.2(c)-365.4(ori)4.2(gi)4.2(ns)-364.1(\(p)4.3(rimary)-364.3(LE\))-364.2(o)-1.4(r)-364.2(m)-2.6(ay)]TJ
0 -1.1174 TD
.0114 Tc
[(occur)-496.5(a)3.4(fter)-496.5(cancer)-496.5(tr)4.6(eat)4.4(ment)-496.7(o)4.5(r)-502.3(t)4.4(r)-1.2(auma)-503.5(\()4.6(s)-1(eco)4.5(ndary)-496.5(LE\))4.6(.)]TJ
0 -1.1116 TD
.0132 Tc
[(He)5.2(alt)6.2(h)-327.7(c)5.2(a)-.6(r)6.4(e)-328.9(p)6.3(r).6(o)6.3(v).6(i)6.2(d).6(er)6.4(s)-327.5(m)5.1(ay)-322(ex)6.3(ce)5.2(l)-327.8(a)5.2(t)-327.8(d)6.3(ia)5.2(gn)6.3(osi)6.2(s)-327.5(w)5.5(i).5(t)6.2(h)-327.7(g)6.3(e)-.6(n)6.3(e)-.6(ti)6.2(c)]TJ
T*
.0071 Tc
[(t)-5.6(e)-.9(s)-5.3(t)-5.6(in)-5.5(g,)-284.3(s)-5.3(c)-.9(r)-5.5(e)-6.7(en)-5.5(in)-5.5(g)-282(d)-5.5(ur)-5.5(in)-5.5(g)-282(a)-6.7(nd)]TJ
12.2221 0 TD
.0087 Tc
[(afte)-5.1(r)-280.3(c)-5.1(ance)-5.1(r)-280.3(t)-4(re)-5.1(a)-5.1(t)1.7(me)-5.1(nt,)-282.7(M)-4.8(LD)-4.8(,)]TJ
-12.2221 -1.1174 TD
.0125 Tc
[(or)-362.9(ly)5.6(mp)5.6(hati)5.5(c)-364.1(m)-1.3(i)5.5(c)-1.3(r)5.7(o)-.1(su)5.6(rg)5.6(er)5.7(ies)5.8(.)-365.3(P)5.8(a)-1.3(ti)5.5(en)5.6(ts)-362.8(may)-363(n)5.6(ot)-363.1(have)-364.1(s)5.8(u)-.1(f)5.7()0(-)]TJ
0 -1.1116 TD
.0119 Tc
[(ci)4.9(ent)-242.8(k)5(nowledg)5(e)-249.5(f)5.1(or)-242.6(di)4.9(scern)5(i)-.8(n)5(g)-248.4(whi)4.9(c)-1.9(h)-242.6(h)-.7(ealt)4.9(h)-242.6(c)-1.9(are)-243.8(pro)5(vi)4.9(ders)]TJ
T*
.0122 Tc
[(can)-317.2(b)5.3(es)5.5(t)-311.6(m)-1.6(eet)-311.6(t)5.2(hei)5.2(r)-311.4(need)5.3(s)-317(a)4.2(nd)-311.4(f)5.4(o)-.4(r)-311.4()-.2(n)5.3(d)-.4(i)5.2(n)-.4(g)-311.4(t)-.5(o)5.3(o)-.4(l)5.2(s)-317(t)5.2(o)-311.4(navi)5.2(gat)5.2(e)]TJ
0 -1.1174 TD
.012 Tc
[(webs)-530.3(o)5.1(f)-530.5(di)5(ff)5.2(erent)-524.9(h)-.6(eal)5(t)-.7(h)-530.5(i)5(nst)5(i)-.7(t)5(u)-.6(t)5(i)-.7(on)5.1(s.)-527.1(Reco)5.1(gn)5.1(ized)-524.7(COEs)]TJ
0 -1.1116 TD
.0125 Tc
[(co)5.6(uld)-391.8(h)-.1(el)5.5(p)-397.5(g)-.1(u)5.6(i)-.2(d)5.6(e)-398.7(pati)5.5(en)5.6(ts)-397.3(t)5.5(hro)5.6(ug)5.6(h)-397.5(t)-.2(h)5.6(e)-398.7(maze)-392.9(of)-397.5(l)5.5(y)-.1(mph)5.6(a)-1.3(ti)5.5(c)]TJ
T*
.0135 Tc
[(ca)5.5(ret)6.5(a)-.3(k)6.6(e)-.3(r)6.7(s)1.1(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 138.7842 Tm
0 Tc
[(Initiation)-336.9(of)-336.6(Committee)-335.3(Work)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 122.3433 Tm
[(LE&RN)-489.1(leadership)-486.8(gathered)-490.5(committee)-488.6(members)-490.3(from)]TJ
-1.0137 -1.1174 TD
[(the)-367.5(lymphatic)-371(community)-370.9(willing)-372(to)-365.2(serve)-370.5(on)-365.1(two)-367.2(separate)]TJ
0 -1.1116 TD
[(committees)-333.9(to)-330.6(provide)-325.8(a)-330.6(system)-331.3(of)-324.7(checks)-332.4(and)-327(balances)-330.2(for)]TJ
T*
[(accountability.)-289.1(The)-282.1(rst/steering)-287.3(committee)-281.2(was)-287.4(responsible)]TJ
0 -1.1174 TD
[(for)-337.3(determining)-332.8(standards)-340.3(for)-331.5(health)-337.5(care)-336.2(providers)-333.5(to)-336.4(meet)]TJ
0 -1.1116 TD
[(to)-244.2(qualify)-245.2(for)-245.1(COE)-248.3(designation)-245(and)-240.6(for)-245.1(drafting)-246.3(applications/)]TJ
T*
[(proposals.)-411.6(The)-403.1(second/global)-409.7(oversight)-408.5(committee)-407.9(was)-402.6(re-)]TJ
25.5097 67.9242 TD
[(sponsible)-414.1(for)-406.4(assessing)-414.8(the)-413.5(standards)-415.1(and)-413.4(judging)-411.2(whether)]TJ
0 -1.1174 TD
[(applicant)-405.5(health)-406.6(care)-405.3(providers/institutions)-405.9(met)-403.2(criteria)-410(for)]TJ
0 -1.1116 TD
[(COE)-282.9(designation.)]TJ
1.0137 -1.1116 TD
[(To)-354.7(draft)-363.8(a)-359.4(list)-361.7(of)-359.3(COE)-363.5(requirements,)-367(the)-355.9(rst)-361.3(committee)]TJ
-1.0137 -1.1116 TD
[(relied)-343.2(on)-347.8(a)-342.1(prominent,)-344.3(established)-349.7(lymphatic)-347.9(physician)-346.4(and)]TJ
0 -1.1174 TD
[(researcher)-552.2(who)-551.3(provided)-551.5(guidance)-548.1(and)-551.6(a)-549.4(comprehensive)]TJ
0 -1.1116 TD
[(list)-229.2(of)-232.6(criteria.)-234.9(Working)-234.7(with)-230.2(the)-235(resulting)-235.9(list,)-232.6(the)-229.2(committee)]TJ
T*
[(discussed)-219.1(each)-221(benchmark)-216.2(through)-220.9(teleconferences,)-223.9(deciding)]TJ
0 -1.1174 TD
[(which)-295.7(points)-288.9(were)-295.6(essential)-301.4(and)-292.4(how)-292.2(and)-292.4(whether)-299(to)-290.3(weight)]TJ
0 -1.1116 TD
[(each.)-345.4(Several)-351(concerns)-351.9(were)-347.4(addressed.)-350.5(First,)-348.6(not)-349(every)-347.6(in-)]TJ
T*
[(stitution)-528.7(has)-528.4(resources)-531.3(to)-526.5(meet)-532.2(each)-526.3(requirement)-535.4(on)-526.3(the)]TJ
0 -1.1174 TD
[(comprehensive)-365.7(list,)-365.1(but)-360.5(many)-363.9(institutions)-359.2(can)-362.7(meet)-365.2(subsets)]TJ
0 -1.1116 TD
[(of)-336.2(the)-344.4(requirements)-346.2(very)-339.6(well.)-338.4(For)-342.9(example,)-344.3(cancer)-339.5(centers)]TJ
T*
[(predominantly)-185.3(see)-184(and)-183(treat)-180.8(cancer-related)-190.8(LE,)-180.8(not)-182(congenital)]TJ
T*
[(LE)-258(or)-261.3(LI,)-260.2(yet)-263.8(premier)-264.8(lymphatic)-261.5(bypass/lymph)-263.2(node)-264.7(transfer)]TJ
0 -1.1174 TD
.0154 Tc
[(surgeons)-429(are)-430.4(o)2.8(fte)-4.1(n)-429.2(located)-429.2(w)]TJ
12.5504 0 TD
.0131 Tc
[(ith)-5.3(in)-431.5(c)-6.4(a)-.7(n)-5.3(cer)-431.5(c)-6.4(e)-.7(n)-5.3(t).4(er)-5.2(s,)-433.8(s)-5.1(o)-431.5(the)]TJ
-12.5504 -1.1116 TD
.0157 Tc
[(standards)-538.1(c)1.9(ommittee)-533.7(determ)]TJ
12.2567 0 TD
.0132 Tc
[(in)-5.2(ed)-540.8(th)-5.2(at)-541(spe)-6.3(c)-.6(i)-5.3(a)-.6(li)-5.3(ze)-6.3(d)-535.1(C)-6.2(OEs)]TJ
-12.2567 -1.1116 TD
.013 Tc
[(co)-5.4(uld)-207(b)-5.4(e)-202.4(d)-5.4(es)-5.2(ig)-5.4(nat)-5.5(e)-.8(d)-5.4(.)-203.5(Se)-6.5(co)-5.4(nd,)-209.3(man)-5.4(y)-207(i).3(n)-5.4(s).6(ti)-5.5(tu)-5.4(ti)-5.5(on)-5.4(s)-201(e)-6.5(xi)-5.5(st)-207.1(as)-206.8(p)-5.4(a)-.8(rt)]TJ
0 -1.1174 TD
[(of)-310.7(la)-6.6(rg)-5.5(er)-310.7(med)-5.5(ica)-6.6(l)-305.1(c)-6.6(a)-.9(m)-6.7(pus)-5.3(es)-5.3(,)-307.3(a)-.9(n)-5.5(d)-305(w)-6.3(h).3(i)-5.6(l).2(e)-311.9(a)-306.1(s)-5.3(i).2(n)-5.5(g).3(le)-311.9(in)-5.5(st)-5.6(it)-5.6(ut)-5.6(ion)]TJ
0 -1.1116 TD
0 Tc
[(ma)-10.3(y)-289.1(n)-6.9(ot)-290.3(b)-6.9(e)-290.2(a)-8(b)0(l)-8.1(e)-290.2(t)-7(o)-289.1(f)-6.8(u)0(l)-8.1()-6.7(ll)-296.2(ev)-9.1(e)-8(r)0(y)-290.1(C)-7.9(O)-7.7(E)-290.3(re)-9.1(q)-6.9(u)0(i)-8.1(r)-6.8(em)-10.3(e)-8(n)0(t)-8.1(,)-291.4(it)-290.4(i)-7(s)-288.9(p)-6.9(o)-6.9(s)0(-)]TJ
T*
[(s)-6.7(i)0(b)-8.1(l)-7(e)-284.5(t)-7(o)-289.1(b)-6.9(ui)-8.1(l)-7(d)-289.1(lo)-8.1(c)-8(a)0(l)-9.3(i)-7(ze)-10.3(d)-289.1(n)-6.9(et)-9.3(w)-7.7(o)0(r)-7.9(k)-6.9(s)-288.9(o)-6.9(f)-283.3(r)-6.8(e)-8(f)-6.8(er)-9.1(r)-6.8(a)0(l)-291.5(t)-7(h)-6.9(a)0(t)-291.5(c)-8(an)-291.3(c)-8(o)-6.9(ll)-8.2(e)-8(c)0(-)]TJ
0 -1.1174 TD
[(ti)-8.2(v)-6.9(e)-8(ly)-290.3(me)-10.3(et)-291.5(CO)-9.9(E)-284.5(n)-6.9(ee)-10.3(d)-6.9(s)-6.7(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 467.5463 Tm
[(Potential)-332.8(Pitfalls)-337.7(Identied)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 451.1054 Tm
[(Th)13.9(e)-382.4(rst)13.1(/st)13.9(an)13.9(dar)12.8(d-s)14.2(ett)12.6(ing)-372.1(com)11.6(mit)12.5(tee)-374.4(rec)11.7(ogn)14(iz)13.8(ed)-383.5(th)15(e)-388.2(nee)17.4(d)]TJ
-1.0137 -1.1174 TD
[(to)-244.2(avo)12.8(id)-250(nu)15.1(mer)11.6(ous)-245(stu)14(mb)13.8(lin)13.7(g)-254.5(blo)13.9(cks)-240.4(in)-250(dra)12.8(fti)13.8(ng)-244.1(sta)12.9(nda)12.8(rds)-239.2(for)]TJ
0 -1.1116 TD
[(COE)16.6(s.)-309.6(COE)-305.9(sta)12.9(tu)15(s)-311.9(can)-305.1(be)-308.6(cov)12.8(ete)11.5(d)-306.4(b)0(y)-307.5(man)11.6(y)-312.1(ins)14(tit)13.6(uti)13.7(ons)-302.6(as)-302.7(a)]TJ
T*
[(fea)11.7(the)18.4(r)-312.1(i)0(n)-301.8(one)12.8(s)-301.5(cap)-299.4(and)-298.2(a)-307.5(luc)12.7(rat)12.7(ive)-298.3(pa)13.9(tie)12.6(nt)-301.8(rec)11.7(rui)13.9(tme)11.5(nt)-301.8(too)13.9(l.)]TJ
T*
[(All)12.8(owi)13(ng)-301.7(eve)11.7(ry)-307.4(phy)14(sic)12.9(ian)-298.3(hop)14(ing)-302.9(to)-307.6(inc)12.7(rea)17.4(se)-308.4(pat)12.7(ien)12.7(t)-312.3(bas)13(e)-307.5(t)0(o)]TJ
0 -1.1174 TD
.0131 Tc
[(be)-346.3(li)-5.4(st)-5.4(ed)-345.1(as)-344.9(a)-340.5(L)-.7(E)-6.5(&)-.7(RN)-346(CO)-6.1(E)-340.5(d)-5.3(eni)-5.4(e)-.7(s)-344.9(p).5(a)-6.4(t).4(i)-5.4(e)-.7(nt)-5.4(s)-344.9(t).4(he)-346.3(s)-5.1(c)-.7(re)-6.4(en)-5.3(ing)]TJ
0 -1.1116 TD
[(pr)-5.3(oce)-6.5(s).6(s)-258.6(t).3(h)-5.4(a)-.8(t)-258.9(can)-258.8(re)-6.5(su)-5.4(lt)-258.9(in)-258.8(bes)-5.2(t)-253.2(p)-5.4(r).4(a)-6.5(c)-.8(t)-5.5(i).3(ce)-6.5(s.)-255.4(I)-5.3(n).4(s)-5.2(t).3(i)-5.5(t).3(u)-5.4(tio)-5.4(n)-253(r)-5.3(en)-5.4(own)]TJ
T*
.0169 Tc
[(i)4.2(n)-185.8(no)4.3(nl)4.2(ymp)4.3(h)-1.5(at)4.2(ic)-186.9(el)4.2(d)-1.5(s)-185.6(c)3.1(ou)4.3(ld)-185.8(mi)]TJ
12.9075 0 TD
.0143 Tc
[(slead)-188.4(L)-5.3(D)-189.3(pa)-5.2(tients.)-190.7(I)-4(mpa)-5.2(r)1.7(tial)]TJ
-12.9075 -1.1174 TD
-.016 Tc
[(judg)-16(i)10.5(n).2(g)-316.6(o).2(f)-316.6(a)-16(p)9.4(p).2(lic)-16(a)8.3(nts)-16(,)-302.6(av)-16(o)10.6(i).1(din)-16(g)-306.2(subj)-16(e)9.3(c)-1(tiv)-16(e)-307.3(c)-1(ron)-16(y)10.6(i)0(sm)-317.8(an)-16(d)-300.4(p)-16(o)10.6(l).1(i-)]TJ
0 -1.1116 TD
-.0155 Tc
[(tics)-15.5(,)-284.8(was)-298.6(d)-15.5(e)9.9(emed)-298.8(as)-298.6(hig)-15.5(h)11.1(est)-299(p).7(r)-15.5(i)11(ori)-15.5(t)10.8(y).7(,)-295.4(s)-15.5(o)-282.4(o)-15.5(b)11.1(j).5(ect)-15.5(i)10.8(v).7(e,)-301.1(measu)-15.5(r)11.1(able)]TJ
T*
.013 Tc
[(re)-6.5(lev)-5.4(a)-.8(n)-5.4(t)-258.9(qu)-5.4(al)-5.5(i)-5.2(cat)-5.5(io)-5.4(ns)-258.6(w)-6.2(e)-.8(r)-5.3(e)-260(ch)-5.4(os)-5.2(en)-258.8(f)-5.3(o).4(r)-264.5(i).2(nc)-6.5(lu)-5.4(si)-5.5(on)-258.8(i)-5.5(n)-258.8(th)-5.4(e)-260(l).3(i)-5.5(s).6(t)]TJ
0 -1.1174 TD
.0126 Tc
[(of)-282.2(s)-5.6(t)-.1(a)-6.9(nda)-6.9(rd)-5.8(s.)]TJ
1.0137 -1.1116 TD
0 Tc
[(Legal)-435.4(liability)-432.3(concerns)-438.3(could)-433(paralyze)-434(efforts)-434.9(to)-434.3(guide)]TJ
-1.0137 -1.1116 TD
[(patients)-201.4(to)-203.9(caretakerswhat)-209.8(if)-203.9(a)-203.8(malpractice)-209.6(situation)-201.5(arises?)]TJ
T*
[(This)-374.2(concern)-374(is)-376.5(not)-372.1(trivialapproximately)-382.3(one)-373.1(third)-374.4(of)-376.5(all)]TJ
0 -1.1174 TD
[(physicians)-301.2(have)-294.7(been)-300.5(sued,)-296.8(according)-301.5(to)-296.1(an)-297.1(American)-302.5(Med-)]TJ
0 -1.1116 TD
[(ical)-271.9(Association)-280.3(survey.)]TJ
7.3823 0 0 6.5614 405.8077 280.1196 Tm
(11)Tj
9.843 0 0 9.843 415.8991 275.7543 Tm
[(LE&RN)-270.2(joins)-276.3(many)-271.7(other)-271.7(disease)]TJ
-10.6727 -1.1116 TD
[(support)-209.2(organizations)-219.6(to)-209.7(include)-217.6(website)-212.6(disclaimer)-217.5(language)]TJ
0 -1.1174 TD
[(to)-278.8(caution)-281(users)-282.7(of)-284.4(limitations.)]TJ
1.0137 -1.1116 TD
.0189 Tc
[(Many)-345.1(LD)-345.9(pati)-5.4(ent)-5.4(s)-339.1(r)-5.2(e)-.6(si)-5.4(de)-340.5(i)-5.4(n)-339.3(ar)-5.2(eas)-344.9(th)-5.2(at)-339.4(a)-6.4(r).6(e)-340.5(u)-5.2(nde)-6.4(rse)-6.4(r).6(ved)]TJ
-1.0137 -1.1116 TD
.0202 Tc
[(by)-274.6(appropria)-5.1(t)1.7(e)-275.8(caregivers.)-271.2(While)-275.8(t)1.7(he)-275.8(standards)-274.4(c).7(ommitte)-5.1(e)]TJ
0 -1.1174 TD
.0186 Tc
[(cou)-5.5(l).1(d)-293.5(not)-293.7(fea)-6.7(s).4(ib)-5.5(ly)-293.5(addr)-5.5(ess)-293.3(t)-5.7(his)-293.3(i).1(mp)-5.5(ort)-5.7(a)-.9(nt)-293.7(lim)-6.8(itat)-5.7(i).1(on)-293.5(in)-293.5(th)-5.5(e)]TJ
0 -1.1116 TD
.0189 Tc
[(app)-5.2(lica)-6.4(tio)-5.2(n/p)-5.2(r).6(opo)-5.2(sal)-5.4(s).7(,)-433.8(i).4(t)-431.6(i)-5.4(s)-431.3(h).5(o)-5.2(p).5(ed)-431.5(t)-5.4(h).5(at)-431.6(L)-6.4(E&RN)-432.3(c)-6.4(hapt)-5.4(ers)]TJ
T*
.0187 Tc
[(can)-397.1(wo)-5.4(rk)-397.1(to)-397.1(sh)-5.4(are)-398.3(i)-5.6(nfor)-5.4(mati)-5.6(on)-397.1(ab)-5.4(out)-397.2(af)-5.4(for)-5.4(d).3(abl)-5.6(e)-398.3(hous)-5.2(ing)]TJ
0 -1.1174 TD
[(and)-460.4(t).2(r)-5.4(a)-.8(ns)-5.2(por)-5.4(tati)-5.6(on)-460.4(opt)-5.6(ion)-5.4(s)-460.3(to)-460.4(pati)-5.6(ent)-5.6(s)-454.5(n)-5.4(eed)-5.4(ing)-460.5(t).2(o)-460.5(t).2(r)-5.4(a)-.8(vel)]TJ
0 -1.1116 TD
[(for)-356.6(care)-6.5(.)]TJ
1.0137 -1.1116 TD
0 Tc
[(Another)-672.2(pitfall)-677.5(the)-672.7(committee)-678.6(wished)-676.7(to)-676.2(avoid)-674.9(was)]TJ
-1.0137 -1.1116 TD
[(exclusivityif)-480.1(an)-475.7(institution)-479.2(was)-477.4(not)-475.7(initially)-478.4(chosen)-481(for)]TJ
0 -1.1174 TD
[(COE)-311.7(status,)-310.6(LE&RN)-310.5(wanted)-315.2(to)-307.6(encourage)-314(the)-315.6(institution)-312.2(to)]TJ
0 -1.1116 TD
[(evolve)-251(to)-250(COE)-254.1(standards.)-251.5(Transparent,)-256.3(objective)-249.9(measurable)]TJ
T*
[(criteria)-266(for)-262.4(application)-269.6(review)-269.1(ensure)-267.9(a)-261.4(level)-267.3(playing)-268.3(eld)-264.7(so)]TJ
0 -1.1174 TD
[(that)-218.9(institutions)-221(vying)-218.7(for)-216.3(COE)-219.5(status)-220.7(can)-218.7(easily)-216.3(discern)-223(steps)]TJ
0 -1.1116 TD
[(needed)-280.8(to)-278.8(strengthen)-284.1(an)-285.6(application.)]TJ
1.0137 -1.1116 TD
[(How)-310.3(to)-313.4(ascertain)-314.1(that)-316.8(each)-313.2(application)-315.6(is)-313.2(truthful)-314.4(and)-315.5(ac-)]TJ
-1.0137 -1.1174 TD
[(curate?)-392.6(While)-389.3(this)-390.4(duty)-390.4(was)-391(assigned)-391(to)-394(the)-390.5(second/global)]TJ
0 -1.1116 TD
[(oversight)-494.9(committee,)-492(the)-494.2(rst/steering)-494.6(committee)-494.3(tried)-496.5(to)]TJ
T*
[(choose)-279.4(metrics)-287.8(that)-282.3(would)-277.2(be)-279.8(easily)-285.5(veriable.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(CENTERS)-336.6(OF)-337.5(EXCELLENCE)-338.1(FOR)-334(LYMPHATIC)-336.9(DISEASE)-27239.9(5)]TJ
ET
endstream
endobj
35 0 obj
<>stream
0 0 0 rg
/GS1 gs
90.709 56.58 .22678 699.874 re
f
119.339 56.58 .22676 699.874 re
f
BT
/F7 1 Tf
0 9.845 -9.845 -0 85.2661 204.1511 Tm
0 Tc
0 Tw
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(1.)Tj
/F7 1 Tf
1.2496 0 TD
[(Centers)-337.2(of)-337(Excellence)-328.8(Standards)-337.3(for)-332.2(Diagnosis)-338.6(and)-332(Care)-333(of)-337(Lymphatic)-335.7(Disease)]TJ
/F10 1 Tf
7.1176 -1.8427 TD
(Comprehensive)Tj
-1.1517 -1.0135 TD
[(Center)-331.8(of)-336.2(Excellence)]TJ
12.1908 1.0135 TD
(Network)Tj
-1.0423 -1.0135 TD
[(of)-330.4(Excellence)]TJ
8.4248 1.0135 TD
[(Referral)-339.7(Network)]TJ
.8004 -1.0135 TD
[(of)-330.4(Excellence)]TJ
7.5322 1.0135 TD
[(LD)-330.9(Surgery)-337.2(Center)]TJ
1.1747 -1.0135 TD
[(of)-330.4(Excellence)]TJ
7.5725 1.0135 TD
[(LD)-336.6(Conservative)-334.3(Care)]TJ
.3455 -1.0135 TD
[(Center)-331.8(of)-336.2(Excellence)]TJ
/F5 1 Tf
-62.2038 -1.8946 TD
(Diagnosis)Tj
.9962 -1.0135 TD
[(Cancer-related)-344.7(or)-330.2(noncancer-related)-342.1(LE)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
(Lipedema)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0077 TD
[(Congenital)-336.2(vascular)-339.7(anomalies,)-339.6(including)-333.1(lymphatic)]TJ
.9847 -1.0135 TD
(malformations)Tj
/F11 1 Tf
27.0767 1.0135 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -2.027 TD
[(Systemic)-339.7(lymphatic)-335.4(disorders)-332.4(\(pleural)-338.9(effusion,)]TJ
.9847 -1.0135 TD
[(pulmonary,)-337.3(chylothorax,)-333.7(protein-losing)-338(enteropathy,)]TJ
0 -1.0077 TD
[(lymphangiectasia,)-337.7(and)-338.1(genital\))]TJ
/F11 1 Tf
27.0767 2.0212 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -3.0348 TD
[(Protein-losing)-337.9(enteropathy)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
(Lymphangiectasia)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0077 TD
[(Lymphaticovenous)-338.6(disease)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Pediatric)-341(lymphatics)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Filariasis,)-338.3(podoconiosis)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Gorhams)-339.1(disease)-338.5(and)-332.4(lymphangiomatosis)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0077 TD
[(Collaboration)-339.4(with)-333.4(practitioner\(s\))-341.4(or)-330.2(facility)-339.2(capable)-334.3(of)]TJ
.9847 -1.0135 TD
[(accurate)-342.2(LD)-332.2(diagnosis)]TJ
/F11 1 Tf
54.6256 1.0135 TD
8.6168 Tc
(XX)Tj
/F5 1 Tf
-56.6065 -2.3322 TD
0 Tc
(Imaging)Tj
.9962 -1.0077 TD
[(Radionuclide)-339.4(lymphoscintigraphy)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Near-infrared)-341(uorescence)-338.9(lymphography)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
(X)Tj
/F5 1 Tf
-55.6103 -1.0135 TD
[(Direct)-337.7(contrast)-338.7(lymphography)-331.1(\(for)-338(cisterna)-334.1(chyli)-334.7(and)]TJ
.9847 -1.0077 TD
[(thoracic)-340(duct)-333.5(visualization\))]TJ
/F11 1 Tf
27.0767 1.0077 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -2.0213 TD
(Venography)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Venous)-336(and)-338.1(lymphatic)-335.4(ultrasonography)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(MRI)-338.8(imaging)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
0 9.845 -9.845 -0 364.1952 494.1353 Tm
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0077 TD
[(MR)-337.8(lymphography)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-45.7747 -1.3187 TD
[(Conservative)-339(management)-333.8(services)]TJ
.9962 -1.0135 TD
[(LE)-338.3(risk)-332.2(reduction)-334.1(and)-338.1(surveillance)-333.6(for)-337(high)-332.4(risk)-332.2(or)]TJ
.9847 -1.0077 TD
[(collaboration)-339.6(with)-333.4(practitioner\(s\))-335.6(who)-337.8(do)-330.2(so)]TJ
/F11 1 Tf
27.0767 1.0077 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
8.6168 Tc
(XX)Tj
/F5 1 Tf
-55.6103 -2.0213 TD
0 Tc
[(Complete)-341(lymphatic)-335.4(decongestive)-333.5(therapy)-337.7(\(intensive)]TJ
.9847 -1.0135 TD
(treatment5)Tj
/F9 1 Tf
5.4706 0 TD
()Tj
/F5 1 Tf
.7198 0 TD
[(/week,)-334.1(60-minute)-334.1(sessions\),)-335.4(LANA-)]TJ
-6.1904 -1.0135 TD
[(certied)-322.6(or)-318.7(equivalent)-324.9(practitioner\(s\),)-321.7(and)-320.9(short-stretch)]TJ
0 -1.0077 TD
[(bandaging)-333.9(expertise)]TJ
/F11 1 Tf
27.0767 3.0348 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
20.2816 0 TD
(X)Tj
/F5 1 Tf
-65.06 -4.0483 TD
[(Maintenance)-340.4(treatment,)-340(including)-333.1(garment)-333.1(tting,)]TJ
.9847 -1.0135 TD
[(dispensation)-239(of)-238.1(medical)-236.5(bandages,)-239.2(garments,)-239.4(pneumatic)]TJ
0 -1.0077 TD
[(compression,)-340.1(and)-332.4(other)-334.5(medical)-334.4(goods)]TJ
/F11 1 Tf
27.0767 2.0213 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
20.2816 0 TD
(X)Tj
/F5 1 Tf
-65.06 -3.0348 TD
[(Management)-339.2(and)-332.4(surveillance)-339.4(of)-336(head/neck)-336.2(LE)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
20.2816 0 TD
(X)Tj
/F5 1 Tf
-65.06 -1.0135 TD
[(Management)-339.2(of)-336(vascular)-333.9(and)-338.1(other)-334.5(complex)]TJ
.9847 -1.0135 TD
[(malformations)-340.4(for)-331.2(overlapping)-336.1(vascular/lymphatic)]TJ
0 -1.0077 TD
(conditions)Tj
/F11 1 Tf
27.0767 2.0213 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
20.6847 -3.7431 TD
(\()Tj
/F10 1 Tf
.334 0 TD
(continued)Tj
/F5 1 Tf
3.9619 0 TD
(\))Tj
/F3 1 Tf
8.9663 0 0 8.9663 304.611 34.2425 Tm
(6)Tj
ET
endstream
endobj
42 0 obj
<>stream
0 0 0 rg
/GS1 gs
72.737 56.58 .22678 699.874 re
f
101.594 56.58 .28346 699.874 re
f
BT
/F7 1 Tf
0 9.845 -9.845 -0 67.2378 358.1857 Tm
0 Tc
0 Tw
(Table)Tj
/F5 1 Tf
3.0002 0 TD
[(1.)-499.6(\()]TJ
/F7 1 Tf
1.5836 0 TD
(Continued)Tj
/F5 1 Tf
4.8948 0 TD
(\))Tj
/F10 1 Tf
-13.7572 -1.8715 TD
(Comprehensive)Tj
-1.1517 -1.0135 TD
[(Center)-331.8(of)-336.2(Excellence)]TJ
12.1908 1.0135 TD
(Network)Tj
-1.0423 -1.0135 TD
[(of)-330.4(Excellence)]TJ
8.4248 1.0135 TD
[(Referral)-339.7(Network)]TJ
.8004 -1.0135 TD
[(of)-330.4(Excellence)]TJ
7.5322 1.0135 TD
[(LD)-330.9(Surgery)-337.2(Center)]TJ
1.1747 -1.0135 TD
[(of)-330.4(Excellence)]TJ
7.5725 1.0135 TD
[(LD)-336.6(Conservative)-334.3(Care)]TJ
.3455 -1.0135 TD
[(Center)-331.8(of)-336.2(Excellence)]TJ
/F5 1 Tf
-61.2076 -1.9003 TD
[(Management)-241.3(of)-238.1(protein-losing)-240.1(enteropathies,)-240.1(chylothorax,)]TJ
.9847 -1.0077 TD
[(chyloperitoneum,)-340.1(and)-332.4(management)-339.6(of)-330.2(mTOR)]TJ
0 -1.0135 TD
[(inhibitors/other)-340.4(pharmacotherapies)-336.2(for)-337(lymphatic)]TJ
T*
[(malformations)-340.4(and)-332.4(complex)-333.1(vascular)-339.7(lesions)]TJ
/F11 1 Tf
27.0767 3.0348 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-45.7747 -4.3477 TD
[(Assessment)-336.2(tools)]TJ
.9962 -1.0135 TD
[(Perometer,)-339.4(bioimpedance,)-338.2(truncated)-335.2(cone/tape)]TJ
.9847 -1.0135 TD
[(measurement,)-338(or)-336(other)-334.5(serial)-336.7(measurement)-334.6(modality)]TJ
0 -1.0077 TD
(expertise)Tj
/F11 1 Tf
27.0767 2.0212 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -3.0348 TD
[(Risk)-339(assessment)-336.5(using)-333.2(perometry)-335.1(or)-336(bioimpedance)]TJ
.9847 -1.0135 TD
(spectroscopy)Tj
/F11 1 Tf
27.0767 1.0135 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-45.7747 -2.3265 TD
[(Interventional)-334.8(therapies)]TJ
.9962 -1.0135 TD
[(Venoplasty)-335.7(and)-332.4(stenting)-331.9(for)-331.2(venous)-329.4(lesions)-330.6(presenting)-334.9(as)]TJ
.9847 -1.0135 TD
[(LE)-338.3(\(including)-334.1(ovarian)-331.9(vein)-333.5(ablation\))]TJ
/F11 1 Tf
27.0767 1.0135 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -2.0213 TD
[(Venous)-336(and)-338.1(lymphatic)-335.4(sclerotherapy)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Thoracic)-341(duct)-333.5(embolization)-334(for)-337(plastic)-337.9(bronchitis,)]TJ
.9847 -1.0135 TD
[(chylothorax,)-339.4(and)-332.4(chyloperitoneum)]TJ
/F11 1 Tf
27.0767 1.0135 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -2.027 TD
[(Sclerotherapy)-340.2(for)-331.2(macrocystic)-339.4(lymphatic)-335.4(malformations)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-45.7747 -1.313 TD
(Surgical)Tj
.9962 -1.0135 TD
[(Suction-assisted)-301.5(lipectomy)-295.1(\(including)-293.8(surgical)-298.4(follow-up\))]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
(X)Tj
/F5 1 Tf
-55.6103 -1.0135 TD
[(Tumescent)-337.2(liposuction)-340.8(for)-331.2(lipedema)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
(X)Tj
/F5 1 Tf
-55.6103 -1.0077 TD
[(Lymphaticovenous)-338.6(anastomosis)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
(X)Tj
/F5 1 Tf
-55.6103 -1.0135 TD
[(Vascularized)-341.2(lymph)-334.5(node)-333.4(transfer)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
(X)Tj
/F5 1 Tf
-55.6103 -1.0135 TD
[(Pleurodesis)-341.3(and)-332.4(shunts)-334(for)-331.2(chronic)-337.7(effusive)-338.5(disorders)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
/F11 1 Tf
10.8318 0 TD
(X)Tj
/F5 1 Tf
-55.6103 -1.0077 TD
[(Collaboration)-339.4(with)-333.4(a)-336.2(facility)-333.4(or)-336(practitioner)-338.6(meeting)]TJ
.9847 -1.0135 TD
[(conservative)-339.2(care)-335.7(COE)-334.2(criteria)]TJ
-1.9809 -1.3187 TD
(Genetics)Tj
.9962 -1.0078 TD
[(Screening)-340.7(for)-331.2(known)-334(genes)-335.4(and)-332.4(mutations)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Genetic)-339.9(counseling)-334.9(to)-336.2(patients)-333.1(and)-338.1(families)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
0 9.845 -9.845 -0 395.2629 507.2314 Tm
[(or)-336(local)-335.9(referral)]TJ
-45.7747 -1.3187 TD
(Consultative)Tj
.9962 -1.0077 TD
[(Psychiatric/psychological)-343.4(services)-339.5(for)-331.2(depression)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Pulmonary)-339.5(medicine)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
(Gastroenterology)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0077 TD
(Gynecology)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
(Oncology)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Diagnostic)-341.7(and)-332.4(interventional)-335(radiology)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
(Dermatology)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0077 TD
(Urology)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Radiation)-341(oncology)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Nutrition)-338.7(\(particularly)-333.8(for)-337(protein-losing)-332.3(enteropathy)-337.2(and)]TJ
.9847 -1.0135 TD
[(lipedema)-335.4(patients\))]TJ
/F11 1 Tf
27.0767 1.0135 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -2.0212 TD
(Neurology)Tj
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
-44.7785 -1.0135 TD
[(Plastic)-337.7(surgery)]TJ
/F11 1 Tf
28.0614 0 TD
4.7701 Tc
(XX)Tj
/F5 1 Tf
6.939 0 TD
0 Tc
[(or)-330.2(afliate)-340(referral)]TJ
/F11 1 Tf
8.4478 0 TD
(X)Tj
/F5 1 Tf
1.3302 0 TD
[(or)-336(local)-335.9(referral)]TJ
20.6847 -1.7218 TD
(\()Tj
/F10 1 Tf
.334 0 TD
(continued)Tj
/F5 1 Tf
3.9619 0 TD
(\))Tj
/F3 1 Tf
8.9663 0 0 8.9663 302.3999 34.2425 Tm
(7)Tj
ET
endstream
endobj
46 0 obj
<>stream
0 0 0 rg
/GS1 gs
468.34 56.58 .28345 699.874 re
f
139.748 56.58 .22678 699.874 re
f
168.605 56.58 .28346 699.874 re
f
BT
/F7 1 Tf
0 9.845 -9.845 -0 134.2488 358.1857 Tm
0 Tc
0 Tw
(Table)Tj
/F5 1 Tf
3.0002 0 TD
[(1.)-499.6(\()]TJ
/F7 1 Tf
1.5836 0 TD
(Continued)Tj
/F5 1 Tf
4.8948 0 TD
(\))Tj
/F10 1 Tf
-13.7572 -1.8715 TD
(Comprehensive)Tj
-1.1517 -1.0135 TD
[(Center)-331.8(of)-336.2(Excellence)]TJ
12.1908 1.0135 TD
(Network)Tj
-1.0423 -1.0135 TD
[(of)-330.4(Excellence)]TJ
8.4248 1.0135 TD
[(Referral)-339.7(Network)]TJ
.8004 -1.0135 TD
[(of)-330.4(Excellence)]TJ
7.5322 1.0135 TD
[(LD)-330.9(Surgery)-337.2(Center)]TJ
1.1747 -1.0135 TD
[(of)-330.4(Excellence)]TJ
7.5725 1.0135 TD
[(LD)-336.6(Conservative)-334.3(Care)]TJ
.3455 -1.0135 TD
[(Center)-331.8(of)-336.2(Excellence)]TJ
/F5 1 Tf
-62.2038 -1.8946 TD
(Research)Tj
.9962 -1.0135 TD
[(Basic/animal)-341.7(lymphatic)-335.4(science,)-337.5(publications)]TJ
/F11 1 Tf
25.971 0 TD
(X)Tj
/F5 1 Tf
1.336 0 TD
(preferred)Tj
-27.307 -1.0135 TD
[(Applied/clinical)-339.3(studies)-336.3(or)-336(trials,)-333.3(reporting)-338.7(in)]TJ
.9847 -1.0135 TD
(ClinicalTrials.gov)Tj
-.9847 -1.0077 TD
[(Recruitment)-339.6(of)-336(patients)-333.1(to)-336.2(the)-332.6(International)-339.6(Lymphatic)]TJ
.9847 -1.0135 TD
[(Disease)-339.3(Registry)-332.7(and)-338.1(Biorepository)]TJ
/F11 1 Tf
27.0767 1.0135 TD
8.7838 Tc
[(XX)391.6(X)909.9(X)167(X)]TJ
/F5 1 Tf
-28.0614 -2.027 TD
0 Tc
[(Infrastructure)-340(to)-336.2(support)-329.4(future)-335.5(research)-340.7(endeavors)]TJ
-.9962 -1.3129 TD
(Accountability)Tj
.9962 -1.0135 TD
[(Participation)-339.6(in)-336.2(patient)-332.3(experience)-338.4(survey)-335.2(network)]TJ
T*
[(Reporting)-339.7(of)-330.2(patient)-338(outcomes,)-337.3(at)-331.6(least)-335.7(short-term)]TJ
.9847 -1.0077 TD
(outcomes)Tj
-1.9809 -1.3187 TD
(Collegiality)Tj
.9962 -1.0135 TD
[(Attendance/participation)-345.1(in)-330.4(at)-337.3(least)-335.7(one)-332.4(LE&RN-)]TJ
.9847 -1.0077 TD
[(associated)-337.1(event/year)]TJ
/F11 1 Tf
27.0767 1.0077 TD
8.7838 Tc
[(XX)391.6(X)909.9(X)167(X)]TJ
/F5 1 Tf
-28.0614 -2.0212 TD
0 Tc
[(Attendance/participation)-345.1(in)-330.4(other)-340.3(lymphatic/scientic)]TJ
.9847 -1.0135 TD
(meetings)Tj
-.9847 -1.0135 TD
[(Patient)-337.9(education)]TJ
0 -1.0077 TD
[(Vascular)-340.5(surgeon)-336.2(education)]TJ
0 -1.0135 TD
[(Physician/therapist)-340.7(education/workshops)]TJ
/F11 1 Tf
28.0614 0 TD
8.7838 Tc
(XX)Tj
/F5 1 Tf
-29.0576 -1.313 TD
0 Tc
(Administration)Tj
.9962 -1.0135 TD
[(Sufcient)-339.5(administrative)-336(resources)-340.3(to)-330.4(handle)-336.7(phone)]TJ
.9847 -1.0135 TD
[(calls/emails)-340.7(inquiring)-331.9(of)-336(services)]TJ
-.9847 -1.0135 TD
[(Participation)-339.6(in)-336.2(LE&RN)-332.7(collaborative)-340.7(administration)-334.8(of)]TJ
.9847 -1.0077 TD
(COEs)Tj
-1.9809 -1.3187 TD
(Community)Tj
.9962 -1.0135 TD
[(Resources/referrals)-343.4(for)-337(need-based)-336.9(nancial)-334.1(assistance)]TJ
/F10 1 Tf
0 -1.0077 TD
[(Pro)-338(bono)]TJ
/F5 1 Tf
4.1692 0 TD
[(services,)-337.1(where)-336.4(appropriate)]TJ
-4.1692 -1.0135 TD
[(Resources/referrals)-343.4(for)-337(patient)-332.3(travel)-336.9(assistance)]TJ
0 8.7511 -8.7511 -0 480.4156 64.5165 Tm
-.0001 Tc
[(LD,)-264.4(lymphatic)-257.8(disease;)-267.1(LE,)-258.3(lymphedema;)-262(MRI,)-263.1(magnetic)-265.7(resonance)-263.4(imaging)5.4(;)-263.3(MR,)-259.2(magnetic)-261.4(resonance;)-267.4(LE&RN,)-261.9(Lymphatic)-261.7(Education)-264.1(and)-256.9(Research)-267(Network;)]TJ
64.5504 0 TD
0 Tc
[(COE,)-265.6(Center)-260.7(of)-261.8(Excellence;)-264(LANA,)]TJ
-65.4574 -1.0236 TD
-.0001 Tc
[(Archaeology)-336.4(Association)-334.7(of)-333.2(North)-330.7(America.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 304.611 34.2425 Tm
0 Tc
(8)Tj
ET
endstream
endobj
50 0 obj
<>stream
/GS1 gs
BT
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 725.7825 Tm
0 0 0 rg
0 Tc
0 Tw
[(Perspective)-339.9(Is)-330.4(Everything)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 709.3416 Tm
-.0216 Tc
[(Thr)-5.4(ougho)-5.4(ut)-339.6(the)-346.4(s).5(tan)-5.4(d).3(ard-d)-5.4(r).4(afti)-5.5(ng)-339.5(act)-5.5(ivity)-5.4(,)-341.8(t).2(he)-340.6(r)-5.4(st)-339.6(co)-5.4(mmit-)]TJ
-1.0137 -1.1116 TD
[(t)-5.5(e)-.8(e)-271.5(a)-.8(tte)-6.6(mpted)-270.4(t)-5.5(o)-270.4(s).5(ee)-277.3(COE)-271.6(s).5(t)-5.5(a)-.8(tus)-270.2(f)-5.4(rom)-271.6(a)-271.5(p)-5.4(a)-.8(tient)-5.5(s)-270.2(pe)-6.6(rspec)-6.6(tive)]TJ
0 -1.1174 TD
.0128 Tc
[(h)-5.6(o).2(w)-265.6(e)-6.7(as)-5.4(y)-264.8(w)-.7(ou)-5.6(ld)-264.8(a)-6.7(n)-264.8(in)-5.6(st)-5.7(it)-5.7(uti)-5.7(o).2(n)-264.8(o)-5.6(r)-264.7(n).2(e)-6.7(t).1(w)-6.4(ork)-264.8(m)-6.8(a)-1(k)-5.6(e)-265.9(a)-265.9(p).2(at)-5.7(ie)-6.7(nt)-5.5(s)]TJ
0 -1.1116 TD
.013 Tc
[(q)-5.4(u).4(e)-6.5(s).6(t)-282(f)-5.3(or)-281.8(a)-6.5(ccu)-5.4(ra)-6.5(te)-283(ti)-5.5(me)-6.5(ly)-281.8(di)-5.5(ag)-5.4(no)-5.4(si)-5.5(s)-281.6(a)-.8(nd)-281.8(o)-5.4(p).4(t)-5.5(i).3(ma)-6.5(l)-282(c)-.8(a)-6.5(r).4(e)-6.5(?)]TJ
1.0137 -1.1116 TD
.0153 Tc
[(The)-361.3(c)1.5(ommittee)-361.3(also)-365.9(strive)]TJ
11.0702 0 TD
.3759 Tc
[(dt)357.4(os)357.7(e)362.1(e)-.7(C)362.3(O)356.7(E)362.1(s).6(f)357.6(r)363.3(o)357.5(m)-.8(t)363.2(h)357.5(ep)363.3(e)356.4(r)363.3(-)]TJ
-12.0839 -1.1174 TD
.0128 Tc
[(s)-5.4(p).2(e)-6.7(c)-1(t)-5.7(i).1(ve)-479(o)-5.6(f)-472.1(d)-5.6(o).2(c)-6.7(t).1(or)-5.5(s)-477.7(a)-1(n)-5.6(d)-472.1(o)-5.6(t).1(h)-5.6(e)-1(r)-477.8(h).2(e)-6.7(a)-1(lt)-5.7(h)-477.9(car)-5.5(e)-479(pro)-5.6(fe)-6.7(ss)-5.4(io)-5.6(nal)-5.7(s).4(.)]TJ
0 -1.1116 TD
.0178 Tc
[(Ph)5.2(ys)5.4(ici)5.1(a)-1.7(n)5.2(s)-196.2(and)-190.6(i)-.7(n)5.2(s)-.4(t)5.1(i)-.7(t)5.1(u)5.2(ti)5.1(on)5.2(s)-196.2(a)4(re)-191.8(su)5.2(bj)5.1(ect)-190.8(t)-.7(o)-190.6(r)-.5(evi)5.1(e)4(w)-197.3(b)5.2(y)-196.4(i)5.1(ns)5.4(ur)5.2(er)5.2(s)]TJ
T*
.013 Tc
[(a)-6.5(n).4(d)-253(g).4(o)-5.4(v).4(er)-5.3(ni)-5.5(ng)-253(ag)-5.4(en)-5.4(cie)-6.5(s)-247.1(f)-5.3(o).4(r)-253(e)-.8(f)-5.3(f).4(e)-6.5(c)-.8(t)-5.5(i).3(v)-5.4(e)-.8(ne)-6.5(ss)-252.8(of)-253(ca)-6.5(re)-254.2(gi)-5.5(ve)-6.5(n)-247.3(a)-6.5(nd)]TJ
T*
.0128 Tc
[(a)-6.7(v).2(o)-5.6(i).1(da)-6.7(nc)-6.7(e)-323.5(o).2(f)-328.1(m)-1(is)-5.4(di)-5.7(ag)-5.6(nos)-5.4(is)-5.4(,)-324.7(f)]TJ
12.0608 0 TD
.0143 Tc
[(a)-5.2(i)1.6(led)-320.9(c)-5.2(are)-5.2(,)-323.2(and)-326.6(o)1.7(ther)-326.6(medic)-5.2(al)]TJ
-12.0608 -1.1174 TD
.0159 Tc
[(m)-3.7(i)3.2(stakes.)]TJ
1.0137 -1.1116 TD
0 Tc
[(While)-210.8(cherry)-216.2(picking)-210.7(of)-209.5(patients)-207.2(can)-213(be)-210.7(used)-212.7(by)-209.5(physicians)]TJ
-1.0137 -1.1116 TD
[(to)-342.1(facilitate)-338.8(best)-339.6(reviews,)-342.6(a)-336.3(properly)-338.3(structured)-341.6(COE)-340.5(desig-)]TJ
0 -1.1174 TD
[(nation)-347.9(process)-349.4(could)-346.6(ensure)-348.5(that)-351.4(the)-344.4(right)-345.6(patients)-351.2(seek)-346.4(out)]TJ
0 -1.1116 TD
[(the)-384.7(right)-380.1(doctors)-383.2(and)-384.6(therapists)-381.9(to)-382.5(the)-379(benet)-383.3(of)-382.3(everyone.)]TJ
T*
[(Physicians)-387.4(do)-382.3(not)-383.6(want)-386.7(patients)-385.7(who)-384.3(have)-381.1(inaccurately)-388(at-)]TJ
0 -1.1174 TD
[(tempted)-478.1(to)-468.9(self-diagnose)-472.6(and)-471(demand)-476.7(inappropriate)-473.2(treat-)]TJ
0 -1.1116 TD
[(ment.)-246.5(A)-13.5(n)-260.3(e)-13.8(x)-18.4(a)-13.8(m)-13.8(p)-18.4(l)-12.7(e)-261.4(w)-13.5(o)-18.4(u)-12.6(l)-18.5(d)-254.5(b)-18.4(e)-255.7(a)-13.8(n)-260.3(L)-13.8(E)-261.5(p)-12.6(a)-19.5(t)-12.7(i)-12.7(e)-19.5(n)-12.6(t)-260.4(w)-13.5(i)-18.5(t)-12.7(h)-260.3(e)-13.8(s)-18.2(t)-12.7(a)-13.8(b)-18.4(l)-12.7(i)-18.5(s)-12.4(h)-18.4(e)-13.8(d)]TJ
T*
.013 Tc
[(d)-5.4(i).3(s)-5.2(e)-.8(a)-6.5(s).6(e,)-313(wit)-5.5(h)-304.9(s)-5.2(i).3(g)-5.4(n).4(i)-5.5().6(ca)-6.5(nt)-310.8(su)-5.4(bd)-5.4(erm)-6.6(a)-.8(l)-310.8(a)-.8(di)-5.5(po)-5.4(se)-311.8(acc)-6.5(umu)-5.4(l).3(a)-6.5(t).3(i)-5.5(on,)]TJ
0 -1.1174 TD
.0144 Tc
[(noncom)-5.2(pliant)-493.7(w)-4.8(ith)-499.3(compression)-493.5(u)-4(se)-5.1(,)-490.1(a)-5.1(nd)-499.3(who)-499.3(d)1.8(em)-5.2(ands)]TJ
0 -1.1116 TD
.0129 Tc
[(l)-5.6(y).3(m)-6.7(pha)-6.6(ti)-5.6(c)-196.7(m)-.9(i)-5.6(c)-.9(r)-5.4(o).3(s)-5.3(urg)-5.5(er)-5.4(y.)-197.9(S)-5.3(t).2(ud)-5.5(ie)-6.6(s)-195.4(h)-5.5(av)-5.5(e)-196.7(p).3(r)-5.4(o).3(v)-5.5(e)-.9(n)-195.5(t)-5.6(ha)-6.6(t)-195.7(L)-.9(V)-6.3(B)-196.6(a)-6.6(n).3(d)]TJ
T*
-.0158 Tc
[(V)-15.8(L)8.7(NT)-392.5(micr)-15.8(o)10.8(s).6(ur)-15.8(g)10.8(e)-.8(ri)-15.8(e)9.5(s)-391.1(wor)-15.8(k)-380.8(best)-391.4(f)-15.8(o)10.8(r)-391.2(ear)-15.8(l)10.7(y)-391.3(not)-15.8(-)10.7(a)-.8(s-)-15.8(e)9.7(s).6(ta)-15.8(b)9.6(lis)-15.8(h)11(e)-.8(d)]TJ
T*
.0155 Tc
[(L)-4.1(E)1.7(,)-218.3(w)2(hile)-217.1(lymphatic-sparing)-221.7(l)]TJ
12.3373 0 TD
.0129 Tc
[(i)-5.6(pos)-5.3(uc)-6.6(ti)-5.6(on)-218.6(ma)-6.6(y)-218.6(w)-.6(o)-5.5(r).3(k)-224.3(b).3(es)-5.3(t)-218.7(f)-5.4(or)]TJ
-12.3373 -1.1174 TD
.018 Tc
[(th)5.4(os)5.6(e)-571.7(w)4.5(it)5.3(h)-570.6(l)5.3(on)5.4(g-)5.4(st)5.3(an)5.4(d)5.4(i)-.5(n)5.4(g)-.4(,)-567.2(a)4.2(di)5.3(po)5.4(se-p)5.4(r)5.4(e)-1.5(v)5.4(a)-1.5(l)5.3(e)4.2(nt)-570.7(est)5.3(a)4.2(bl)5.3(is)5.6(hed)]TJ
0 -1.1116 TD
.0196 Tc
[(LE)5.8(.)]TJ
7.3823 0 0 6.5614 74.7779 461.6503 Tm
.0222 Tc
[(121)7.7(5)]TJ
9.843 0 0 9.843 98.022 457.2849 Tm
.0151 Tc
[(The)-407.6(c)1.3(ommitte)-4.4(e)-407.6(a)1.3(tte)-4.4(m)1.3(pted)-406.5(to)-406.5(present)-406.6(C)-4.3(OE)-407.6(sta)-4.4(n)2.5(-)]TJ
-3.8878 -1.1116 TD
.0129 Tc
[(d)-5.5(a)-.9(r)-5.4(d).3(s)-206.9(t)-5.6(ha)-6.6(t)-207.2(h).3(e)-6.6(l).2(p)-207.1(g)-5.5(ui)-5.6(de)-208.2(p)-5.5(a)-.9(t)-5.6(i).2(en)-5.5(ts)-212.6(to)-207.1(t)-5.6(h).3(e)-214(a)-.9(pp)-5.5(ro)-5.5(pr)-5.4(iat)-5.6(e)-.9(,)-209.4(n).3(o)-5.5(t)-207.2(me)-6.6(re)-6.6(ly)]TJ
0 -1.1174 TD
.0131 Tc
[(d)-5.3(e)-.7(s)-5.1(i).4(r)-5.2(e)-.7(d,)-284.1(tr)-5.2(ea)-6.4(tme)-6.4(n).5(t)-5.4(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 412.7243 Tm
0 Tc
[(The)-338.2(Standards)-334.4(Committees)-336.9(Recommendations)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 396.2834 Tm
.0123 Tc
[(Table)-197.3(1)-190.4(list)5.3(s)-195.9(sugg)5.4(ested)-196.1(e)-1.5(xp)5.4(erti)5.3(se)-197.3(requi)5.3(rements)-196(i)5.3(n)-196.1(m)-1.5(u)5.4(ltip)5.4(le)]TJ
-1.0137 -1.1116 TD
[(cat)5.2(egor)5.4(ies.)-388.6(P)5.5(roper)-392(d)5.3(iag)5.3(nosi)5.2(s)-391.9(of)-386.3(LD)-392.9(n)5.3(ecessitates)-386.1(c)-1.6(on)5.3(sider-)]TJ
T*
.0126 Tc
[(atio)5.7(n)-241.9(o)0(f)-241.9(c)-1.2(o)5.7(m)-1.2(pl)5.6(ex)-241.9(syn)5.7(dromes,)]TJ
12.1242 0 TD
.0121 Tc
[(accurate)-243.6(ph)5.2(ysical)-242.6(ass)5.4(e)-1.7(ssment,)]TJ
-12.1242 -1.1174 TD
[(and)-271.3(k)5.1(nowledg)5.1(e)-272.5(o)-.6(f)-271.3(g)5.1(enetic)-272.5(and)-271.3(e)-1.8(n)5.1(v)-.6(iro)5.1(n)-.6(mental)-271.4(con)5.1(t)-.7(rib)5.1(u)-.6(tio)5.1(ns)]TJ
0 -1.1116 TD
-.0157 Tc
[(t)-15.7(o)-208.1(LD.)-220.7(I).5(ma)-15.7(g)9.7(i).4(ng)-224.1(is)-218.2(an)-224.1(impo)-15.7(r)10.9(t).4(ant)-224.3(p).5(art)-224.3(o).5(f)-218.4(a)-15.7(n)-209.1(e)-.7(xami)-15.7(n)10.8(a)-.7(ti)-15.7(o)10.8(n)-218.4(wo)-15.7(r)10.9(kup,)]TJ
T*
0 Tc
[(and)-246.4(mag)11.6(net)12.7(ic)-245.4(res)13(ona)12.8(nce)-247.5(ly)15(mph)12.7(ogr)14(aph)12.8(y,)-246.4(lym)12.6(pho)14(sci)12.9(nti)13.7(gra)12.8(phy)19.7(,)]TJ
0 -1.1174 TD
[(nea)11.7(r-i)13.9(nfr)14(are)11.7(d)-306.4(uo)14.1(res)13(cen)11.7(ce)-304(lym)12.6(pho)14(gra)12.8(ph)15.1(y,)-304(and)-298.2(oth)13.9(er)-302.8(mod)12.7(ali)12.6(-)]TJ
0 -1.1116 TD
-.0159 Tc
[(t)-15.9(i)-15.9(e)-3.3(s)-229.9(s)-15.9(h)10.9(oul)-15.9(d)-208.3(b).3(e)-219.7(p)-15.9(a)9.5(r).3(ts)-224.1(of)-218.6(a)-225.5(phys)-15.9(i)10.8(c)-.9(ian)-15.9()10.7(s)-218.4(t)-15.9(o)10.6(o).3(lbo)-15.9(x)10.7(.)-220.9(G)-.6(ene)-15.9(t)9.4(ic)-219.7(s)-15.9(c)9.7(reen)-15.9(i)10.6(n).3(g)]TJ
T*
.0129 Tc
[(a)-6.6(n).3(d)-235.9(c)-6.6(ou)-5.5(ns)-5.3(eli)-5.6(n).3(g)-235.9(m)-6.7(ay)-235.9(b)-5.5(e)-237(re)-6.6(qui)-5.6(re)-6.6(d)-235.9(f).3(o)-5.5(r)-235.8(di)-5.6(sc)-6.6(er)-5.4(ni)-5.6(ng)-235.9(a)-237(h)-5.5(er)-5.4(edi)-5.6(t).2(a)-6.6(r).3(y)]TJ
T*
.0169 Tc
[(basi)4.2(s)-277.7(f)-1.4(o)4.3(r)-277.9(LD)-278.8(i)4.2(n)-277.9(so)4.3(me)-279.1(cases)4.5(.)]TJ
1.0137 -1.1174 TD
.013 Tc
[(A)-6.2(f).4(te)-6.5(r)-195.4(d).4(i)-5.5(a)-.8(gn)-5.4(os)-5.2(is)-5.2(,)-192(p)-5.4(ro)-5.4(per)-195.4(t)-5.5(re)-6.5(atm)-6.6(e)-.8(n)-5.4(t)-189.8(a)-6.5(n).4(d)-195.4(p)-5.4(ati)-5.5(e)-.8(n)-5.4(t)-195.6(com)-6.6(p).4(li)-5.5(an)-5.4(ce)]TJ
-1.0137 -1.1116 TD
.019 Tc
[(ar)6.4(e)-455.6(c)5.2(ru)6.4(ci)6.3(al)-448.8(to)-454.4(s)6.6(a)-.5(t)6.3(i).5(s)6.6(f).7(a)5.2(c)5.2(t).5(o)6.4(r).7(y)-454.4(o)6.4(u)6.4(t).5(c)5.2(o).6(m)5.2(e)5.2(s).8(.)-451(C)-.4(o)6.4(n).6(s)6.6(e)5.2(rv)6.4(at)6.3(iv)6.4(e)-455.6(m)5.2(an)6.4(-)]TJ
T*
.0147 Tc
[(a)-4.8(g)2.1(e)-4.8(ment,)-535.9(including)-533.6(M)-4.6(LD/CD)-4.5(T).9(,)-535.9(pha)-4.8(rm)-4.9(acothera)-4.8(p)2.1(ies,)-530.1(a)-4.8(n)2.1(d)]TJ
0 -1.1174 TD
[(c)-4.7(o)2.2(mpre)-4.7(ssion)-182.1(g)2.2(armen)]TJ
8.5128 0 TD
.0152 Tc
[(t)-181.9()2.7(tting,)-184.1(may)-181.7(be)-182.9(sufc)-4.3(i)2.5(e)-4.3(n)2.6(t)-181.9(f)2.6(or)-181.7(many)-181.7(L)1.4(D)]TJ
-8.5128 -1.1116 TD
0 Tc
[(pat)12.7(ien)12.7(ts.)-431.8(Phy)14.1(sic)12.9(ian)-430.8(exp)12.8(er)14(tis)13.9(e)-445.8(i)0(n)-434.3(int)13.7(er)14(ven)12.8(tio)13.7(nal)-430.8(and)-430.7(sur)14.2(gic)12.7(al)]TJ
T*
[(the)12.7(rap)12.9(ies)12.9(,)-308.7(suc)13(h)-312.1(a)0(s)-308.4(scl)12.9(er)13.9(oth)13.8(era)11.7(py,)-299.4(tho)13.8(rac)11.7(ic)-308.8(duc)12.8(t)-306.5(emb)11.6(oli)13.7(zat)11.5(ion)19.6(,)]TJ
0 -1.1174 TD
[(t)-7(u)-6.9(me)-10.4(s)-6.7(c)0(e)-10.3(n)-6.9(t)-536.9(l)-7(i)-7(p)0(o)-8(s)-6.7(uc)-9.1(t)-7(i)-7(o)0(n)-8(,)-539.1(p)-6.9(l)0(e)-9.2(u)-6.9(ro)-7.9(d)-6.9(e)-8(si)-7.9(s)-6.7(/)0(s)-7.9(h)-6.9(u)-6.9(n)0(t)-8.1(s)-6.7(,)-539.1(a)-8(nd)-543.6(ly)-8.1(m)-8.1(p)0(h)-8(a)-8(t)0(i)-8.2(c)]TJ
0 -1.1116 TD
[(m)-8.1(i)-7(cr)-9.1(o)-6.9(s)0(u)-7.8(r)-6.8(g)-6.9(e)0(r)-9.1(i)-7(es)-8.9(,)-251.1(i)-7(s)-254.3(e)0(s)-8.9(s)-6.7(e)-8(n)0(t)-8.1(i)-7(al)-256.9(f)-6.8(o)0(r)-255.6(t)-7(re)-9.1(a)-8(t)0(m)-9.3(e)-8(nt)-255.8(o)-6.9(f)-248.7(l)-7(y)-6.9(mp)-9.2(h)-6.9(o)0(v)-8(a)-8(s)0(c)-8.9(u)-6.9(la)-9.2(r)]TJ
T*
[(a)-8(n)-6.9(om)-9.2(a)-8(l)0(i)-8.2(e)-8(s,)-286.6(a)-8(s)-283.1(w)-7.7(e)-8(ll)-290.4(as)-291.1(ly)-8.1(m)-8.1(p)0(h)-8(a)-8(t)0(i)-8.2(c)-8(-o)-7.9(n)-6.9(l)-7(y)-283.3(d)-6.9(is)-7.9(e)-8(a)0(s)-8.9(e)-8(s)-6.7(.)]TJ
1.0137 -1.1174 TD
[(Treating)-225.7(only)-223.4(physiological)-230.1(LD)-223.1(symptoms)-224.1(is)-221(not)-222.3(sufcient)]TJ
-1.0137 -1.1116 TD
[(for)-302.7(best)-305(patient)-304.2(outcomes.)-303.7(LE)-298.3(patients,)-302.8(for)-302.7(example,)-304(experi-)]TJ
T*
[(ence)-342(depression)-347.1(at)-337.6(higher)-341.9(than)-339.8(average)-340.6(rates)-341.8(and)-344.3(may)-339.8(need)]TJ
T*
[(counseling)-364.8(and/or)-365(medication)-361.7(for)-360.3(this)-361.6(concern.)-360.2(LE)-361.7(patients)]TJ
0 -1.1174 TD
[(experience)-454.7(cellulitis)-457.4(also)-449(at)-452.7(higher-than-average)-454.3(rates)-451.2(and)]TJ
0 -1.1116 TD
[(may)-270.6(require)-275(dermatological)-269.5(services)-277(or,)-264.8(in)-273(the)-269.5(case)-266.9(of)-272.9(sepsis)]TJ
T*
[(development,)-469.8(hospitalization.)-467.5(LI)-469.9(and)-465.2(protein-losing)-466.1(enter-)]TJ
0 -1.1174 TD
[(opathy)-284.4(patients)-282(can)-282.1(benet)-285.4(from)-282(nutrition)-281.1(counseling.)]TJ
7.3823 0 0 6.5614 272.9763 115.7102 Tm
(16)Tj
9.843 0 0 9.843 69.7323 100.4031 Tm
[(Bas)12(ic)-498.8(sc)14.1(ien)12.7(ce)-499.9(and)-488.3(cli)12.6(nic)12.7(al)-498.8(re)14(sea)11.8(rch)-494(in)-491.9(LDs)-494.8(is)-497.5(now)-488(in-)]TJ
-1.0137 -1.1116 TD
[(cre)11.7(asi)12.9(ng.)-259.1(Adv)13.1(anc)17.4(es)-268.1(in)-261.5(und)14(ers)13(ta)13.8(ndi)13.8(ng)-261.4(the)-258(sci)12.9(enc)11.7(e)-267.2(beh)12.8(ind)-256.9(LDs)]TJ
0 -1.1174 TD
[(dep)12.8(end)-206.1(on)-209.5(dis)14(sem)11.8(ina)12.7(tio)13.7(n)-214.2(o)0(f)-209.5(res)13(ear)11.7(ch)-210.7(nd)14.1(ing)13.8(s)-214(and)-211.8(co)13.9(ope)12.8(rat)12.7(ive)]TJ
0 -1.1116 TD
[(eff)12.9(ort)13.9(s)-260.1(wit)12.8(hin)-251.1(the)-246.5(com)11.6(mun)12.7(iti)19.4(es)-256.6(of)-255.6(car)11.7(eta)11.5(ke)13.9(rs)-255.4(and)-252.1(res)13(ear)11.7(che)17.4(rs.)]TJ
T*
[(LE&)10.4(RN)-223(est)12.9(abl)12.7(ish)14(ed)-228(th)15(e)-232.6(Int)13.9(ern)12.8(ati)12.6(ona)18.6(l)-231.6(Lym)11.6(pha)18.6(tic)-223.6(Dis)13.2(eas)11.8(e)-226.9(and)]TJ
25.5097 67.9242 TD
[(Lym)17.3(phe)12.8(dem)11.6(a)-342.1(Pat)12.8(ien)12.7(t)-341(Reg)11.8(ist)13.9(ry)-336.2(and)-332.8(Bio)12.8(rep)12.8(osi)14(tor)13.9(y)-340.9(i)0(n)-336.4(200)14(9,)]TJ
7.3823 0 0 6.5614 542.6077 729.5242 Tm
(17)Tj
9.843 0 0 9.843 310.8472 714.1605 Tm
[(and)-413.4(re)14(cru)12.8(itm)12.5(ent)-413.5(of)-416.9(pat)12.7(ien)12.7(ts)-416.8(wh)14.2(o)-421.6(wil)12.8(l)-421.7(pro)14(vid)13.9(e)-422.7(hea)11.6(lth)-406.7(inf)13.9(or-)]TJ
0 -1.1116 TD
[(ma)12.7(tio)13.7(n)-214.2(and)-206.1(bio)13.9(log)13.9(ica)11.5(l)-214.3(sam)11.8(ple)12.7(s)-214(t)0(o)-209.7(thi)13.7(s)-214(ban)12.8(k)-214.2(for)-204.8(fut)13.9(ure)-206(res)13(ear)11.7(ch)]TJ
T*
-.0216 Tc
[(endea)-6.6(vors)-195.3(i).2(s)-201.1(i).2(nclud)-5.4(e)-.8(d)-195.5(a)-.8(s)-195.3(a)-196.6(COE)-196.7(c)-.8(r)-5.4(iteri)-5.5(on.)-197.8(Colleg)-5.4(i).2(alit)-5.5(y,)-192.1(as)-201.1(judged)]TJ
T*
-.021 Tc
[(by)-229.5(a)-6(ttenda)-6(nce)-230.6(a)-6(t)-229.6(LE&RN-associated)]TJ
14.1862 0 TD
[(events,)-231.7(physicia)-5.9(n)1(/therapist)]TJ
-14.1862 -1.1174 TD
.0131 Tc
[(ed)-5.3(uca)-6.4(t).4(i)-5.4(o).5(n)-316.3(w)-.4(or)-5.2(ks)-5.1(ho)-5.3(ps)-5.1(,)-312.9(a)-.7(n)-5.3(d)-310.5(o)-5.3(t).4(h)-5.3(e)-.7(r)-316.3(l).4(y)-5.3(m)-.7(ph)-5.3(ati)-5.4(c)-.7(-)-5.2(r).5(e)-6.4(l).4(at)-5.4(ed)-316.3(co)-5.3(nf)-5.2(er-)]TJ
0 -1.1116 TD
.0147 Tc
[(ences,)-276.7(i)-3.8(s)-279.9(a).9(lso)-280.1(i)-3.8(nc)-4.8(luded)-280.1(i)]TJ
9.9355 0 TD
.013 Tc
[(n)-281.8(t).3(h)-5.4(e)-283(li)-5.5(st)-282(o)-5.4(f)-281.8(cr)-5.3(ite)-6.5(ri)-5.5(a.)]TJ
-8.9218 -1.1116 TD
0 Tc
[(Several)-299.1(categories)-309.4(of)-295.9(COE)-305.9(designation)-302.6(allow)-301.5(expertise)-307.2(in)]TJ
-1.0137 -1.1174 TD
[(specialized)-225.5(areas)-221.9(to)-221.2(be)-222.2(recognized)-223.1(when)-219.5(an)-222.2(institution)-220.1(cannot)]TJ
0 -1.1116 TD
[(meet)-324.9(all)-321.5(of)-324.7(the)-321.4(Comprehensive)-331(COE)-323.2(requirements.)-326.6(In)-324.7(addi-)]TJ
T*
[(tion)-229.3(to)-227(the)-229.2(Comprehensive)-233.1(COE)-225.3(designation)-8.9(,)-222.3(four)-229(other)-231.4(COE)]TJ
0 -1.1174 TD
[(categories)-465(are)-460.6(recognized:)-466.3(\(1\))-458.3(Network)-465.7(of)-457.2(Excellence)-467.5(for)]TJ
0 -1.1116 TD
[(afliated)-232.5(institutions;)-233.7(\(2\))-227.9(Referral)-232.2(Network)-235.3(of)-226.8(Excellence)-237.2(for)]TJ
T*
[(nonafliated,)-412(but)-400.9(neighboring)-410.9(institutions;)-406.5(\(3\))-406.4(LD)-407.4(Surgery)]TJ
T*
[(COE)-357.7(for)-354.6(institutions)-359.2(at)-360.6(which)-359(LD)-355.6(microsurgeries)-365.5(and)-355.8(lipo-)]TJ
0 -1.1174 TD
[(suction)-389.1(procedures)-394.4(are)-391.5(the)-390.5(focus)-392.3(of)-393.8(treatment;)-390.6(and)-396.1(\(4\))-389.1(LD)]TJ
0 -1.1116 TD
[(Conservative)-438.2(Care)-439.7(COE)-438.4(for)-435.2(institutions)-439.8(delivering)-434.2(quality)]TJ
T*
(CDT/MLD.)Tj
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 516.8124 Tm
(Conclusions)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 500.3715 Tm
[(Re)18.6(co)19.7(gn)20.8(it)20.6(io)20.7(n)-196.9(o)0(f)-186.5(L)0(D)18.8(s)-202.5(an)19.7(d)-196.9(t)0(h)20.7(e)-198.1(qu)20.8(es)19.9(t)-197.1(f)0(o)20.9(r)-196.9(ca)12.8(re)-187.6(ar)19.7(e)-198.1(m)0(u)19.6(s)0(h)21(r)0(o)20.9(o)0(m)19.6(i)0(n)20.7(g)]TJ
-1.0137 -1.1116 TD
[(ar)19.7(ea)18.5(s)-225.5(o)0(f)-221(h)0(e)19.7(a)0(l)19.5(t)0(h)-215.4(c)0(a)18.5(r)0(e)13.9(.)-222.3(Th)13.9(e)-226.9(c)0(o)19.7(s)0(t)-215.2(f)0(o)15.1(r)-225.7(ca)18.5(ri)20.7(ng)-221.1(fo)20.9(r)-225.7(l)0(y)20.7(m)0(p)19.6(h)0(a)19.7(t)0(i)14.8(c)-226.9(pa)19.7(ti)20.6(en)19.7(ts)]TJ
T*
[(is)-399.6(si)20.9(gn)15.1(i)20.9(ca)18.5(nt)20.7(t)19.6(re)19.7(at)19.5(me)18.4(nt)14.9(s)-409.8(f)0(o)20.9(r)-410(LE)-402(we)18.8(re)-400.7(th)20.7(e)-411.2(1)0(3)15.1(t)0(h)-399.7(m)0(o)19.6(s)0(t)-399.6(o)0(f)20.9(t)0(e)19.5(n)]TJ
T*
[(re)19.7(im)19.5(bu)20.8(rs)15.3(ed)-256.8(pr)20.9(oc)13.9(ed)19.7(ur)20.9(es)-262.4(\($)20.9(49)20.8(8)-271.8(m)0(i)19.5(l)0(l)20.6(i)0(o)20.7(n)0(\))-261.4(i)0(n)-261.5(2)0(0)20.8(1)0(2)-255.6(b)0(y)-261.4(t)0(h)20.7(e)-273(Ce)18.6(nt)20.7(er)19.7(s)]TJ
0 -1.1174 TD
[(fo)20.9(r)-329.4(M)0(e)18.8(d)0(i)20.7(c)0(a)18.5(r)0(e)-320.1(a)0(n)19.7(d)-323.6(Me)18.8(di)20.7(ca)12.8(id)-313.4(Se)19.8(rv)15.1(ic)19.5(es)19.9(.)]TJ
7.3823 0 0 6.5614 457.3416 460.9132 Tm
-.0162 Tc
(18)Tj
9.843 0 0 9.843 467.8298 456.5479 Tm
0 Tc
[(Es)19.8(pe)19.7(ci)13.8(al)19.5(ly)20.7(,)-326(a)0(s)-319.9(L)0(I)-314.4(b)0(e)19.7(-)]TJ
-15.9486 -1.1116 TD
[(co)19.7(me)18.4(s)-363.8(m)0(o)19.6(r)0(e)-348.9(a)0(n)13.9(d)-358.2(mo)19.6(re)-354.7(re)19.7(co)19.7(gn)15.1(iz)19.5(ed)-348.9(as)-354.5(di)20.7(st)15.1(in)20.7(ct)-354.8(fr)20.9(om)-354.8(\(r)20.9(eg)19.7(ul)20.7(ar)19.7(\))]TJ
T*
[(ob)20.8(es)19.9(it)20.6(y,)-281(de)19.7(ma)18.4(nd)-272.9(fo)15.1(r)-283.3(a)0(c)18.5(c)0(u)19.7(r)0(a)14(t)0(e)-274.2(d)0(i)20.7(a)0(g)19.7(n)0(o)15.1(s)0(i)20.9(s)-288.9(an)19.7(d)-283.3(e)0(f)19.7(f)0(e)14(c)0(t)19.6(i)0(v)20.7(e)-284.5(ca)12.8(re)-274(fo)20.9(r)]TJ
0 -1.1174 TD
[(th)20.7(is)-203.7(an)19.7(d)-208.4(o)0(t)20.7(h)0(e)19.7(r)-214.2(LD)18.8(s)-208.3(w)0(i)19.8(l)0(l)-204(p)0(o)20.8(s)0(s)21.2(i)0(b)15(l)0(y)-198.2(r)0(i)20.7(v)0(a)19.7(l)-214.3(th)20.7(at)-199.3(of)-203.8(bl)20.7(oo)20.8(d)-214.2(v)0(a)19.7(s)0(c)19.9(u)0(l)20.7(a)0(t)19.5(u)0(r)15.1(e)]TJ
0 -1.1116 TD
[(di)20.7(so)21(rd)20.9(er)14(s.)-234.7(Th)19.6(er)19.7(e)-249.9(i)0(s)-232.5(a)0(n)-239.5(u)0(r)20.9(g)0(e)19.7(n)0(t)-238.5(n)0(e)19.7(e)0(d)-239.5(t)0(o)-232.7(s)0(e)19.9(t)-248.9(st)20.9(an)19.7(da)19.7(rd)15.1(s)-242.8(f)0(o)15.1(r)-243(op)20.8(ti)14.8(m)15(a)0(l)]TJ
T*
[(LD)-280.7(di)20.7(ag)19.7(no)20.8(si)20.9(s)-288.9(a)0(n)19.7(d)-289.1(ca)18.5(re)19.7(.)-291.4(L)0(E)18.5(&)0(R)18.6(N)0(,)-276.1(b)0(y)-278.7(e)0(s)19.9(t)0(a)19.6(b)0(l)14.9(i)0(s)20.9(h)0(i)20.7(n)0(g)-278.7(C)0(O)18.9(E)-290.3(de)19.7(si)20.9(g-)]TJ
0 -1.1174 TD
[(na)19.7(ti)20.6(on)-249.9(st)20.9(an)19.7(da)13.9(rd)20.9(s)-260.1(f)0(o)20.9(r)-260.3(he)19.7(al)19.6(th)-250(ca)18.5(re)-251(in)20.7(st)20.9(it)20.6(ut)15(io)20.7(ns)21(,)-256.9(i)0(s)-249.8(a)0(d)19.7(d)0(r)15.1(e)0(s)19.9(s)0(i)20.9(n)0(g)-249.9(t)0(h)20.7(i)0(s)]TJ
0 -1.1116 TD
[(ne)19.7(ed)-262.5(an)19.7(d)-266(p)0(u)15.1(s)0(h)21(i)0(n)20.7(g)-271.8(op)20.8(ti)20.6(ma)18.4(l)-271.9(L)0(D)-263.5(p)0(a)19.7(t)0(i)20.6(e)0(n)19.7(t)-271.9(ca)18.5(re)-262.5(fo)20.9(rw)20(ar)19.7(d.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 357.8456 Tm
(Acknowledgments)Tj
/F5 1 Tf
9.843 0 0 9.843 320.8251 341.4046 Tm
[(Critique)-218.7(and)-217.6(suggestions)-220.3(for)-216.3(crafting)-218.7(of)-221(the)-217.7(COE)-219.5(standards)]TJ
-1.0137 -1.1116 TD
[(were)-393.5(provided)-390.2(by)-393.9(members)-392.4(of)-393.8(the)-390.5(second/global)-398.2(oversight)]TJ
0 -1.1174 TD
.0209 Tc
[(committee)-4.4(:)-423.8(P)2.7(e)-4.4(t)2.4(e)-4.4(r)-423.7(Mortim)-4.5(er,)-420.3(H)-4.1(a)]TJ
13.2704 .0346 TD
0 Tc
()Tj
.4032 -.0346 TD
.0186 Tc
[(k)-5.5(a)-.9(n)-426(B)-6.6(ro)-5.5(rs)-5.3(on)-5.5(,)-428.3(M)-.7(i)-5.7(n).2(g)-5.5(-).3(H)-6.4(u).2(ei)]TJ
-13.6735 -1.1116 TD
.0189 Tc
[(Ch)-5.2(en)-5.2(g,)-462.6(Ro)-5.2(be)-6.4(rt)-466.1(Dam)-6.5(s).7(t)-5.4(r).6(a)-6.4(,)-462.6(Sh)-5.2(el)-5.4(do)-5.2(n)-460.2(F).7(e)-6.4(l).4(d)-5.2(m)-.7(a)-6.4(n).5(,)-462.6(E)-.7(m)-6.5(i).4(l)-5.4(y)-460.3(Ik)-5.2(er)-5.2(,)]TJ
T*
.0186 Tc
[(Er)-5.5(ic)-363.8(Jo)-5.5(hn)-5.5(so)-5.5(n,)-365(Gu)-5.5(ent)-5.7(e)-.9(r)-362.6(K)-6.4(lo)-5.5(se)]TJ
12.343 0 TD
.021 Tc
[(,)-356.8(A)1.8(llison)-360.2(C.)-356.8(N)-4(a)1.5(uta,)-362.6(Michael)]TJ
-12.343 -1.1174 TD
.0187 Tc
[(Ob)-5.4(er)-5.4(li)-5.6(n,)-197.8(S)-5.3(t).2(e)-6.6(p).3(h)-5.4(a)-.8(ne)-202.4(Vi)-5.6(og)-5.4(ne)-6.6(s,)-197.8(M)-6.3(i).2(i)-5.6(k).3(k)-5.4(a)-196.7(V)-6.3(i).2(k)-5.4(k).3(u)-5.4(l).2(a)-6.6(,)-197.8(an)-5.4(d)-195.5(J)-5.2(un)-5.4(e)-196.7(W)-1.9(u)-5.4(.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 264.5858 Tm
0 Tc
[(Author)-332.4(Disclosure)-336.7(Statement)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 248.1448 Tm
[(No)-279.5(competing)-284.4(nancial)-283.1(interests)-282.9(exist.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 226.148 Tm
[(Funding)-334.6(Information)]TJ
/F5 1 Tf
9.843 0 0 9.843 320.8251 209.707 Tm
[(No)-279.5(funding)-278.5(was)-281.6(received)-284.3(for)-285.5(this)-280.9(work.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 310.8472 187.7102 Tm
(References)Tj
/F5 1 Tf
9.2951 0 0 9.2951 315.496 171.6094 Tm
[(1.)-500.4(Foldi)-514.8(M,)-517.9(Foldi)-514.8(E.)]TJ
/F10 1 Tf
9.5453 0 TD
[(Foldis)-515.5(Textbook)-516.2(of)-518.2(lymphology)]TJ
/F5 1 Tf
13.5769 0 TD
[(,)-518.5(3rd)]TJ
-21.8719 -1.1223 TD
[(edition.)-332.9(Munich,)-333.2(Germany:)-335.7(Elsevier)-341.1(GmbH;)-332.2(2012.)]TJ
-1.2503 -1.1284 TD
[(2.)-500.4(L)16.3(e)14(v)18.2(i)12.6(c)14(k)-244.1(J)12.9(R)13.4(,)-244(M)12.8(i)18.7(c)14(he)26(l)-243.5(C)13.4(C)13.4(.)-244(M)12.8(i)18.7(c)14(r)15.8(ov)30.2(a)14(s)12.9(c)14(u)0(l)30.8(a)14(r)-246.4()15.3(ui)30.8(d)-244.1(e)14(xc)26(h)18.2(a)14(ng)30.2(e)-248.3(a)14(nd)-232.1(t)18.7(h)0(e)]TJ
1.2503 -1.1223 TD
-.0167 Tc
[(revi)-4.1(s)-3.8(e)-2.7(d)-260.8(S)-1.4(tarl)-4.1(i)-4.1(n)1.5(g)-260.8(p)-16.7(r)11.2(i)-4.1(nci)-4.1(p)1.5(l)-4.1(e)-2.7(.)-260.7(C)-3.3(ardi)-4.1(ov)-16.7(a)9.3(s)-3.8(c)-258.9(R)-3.3(es)-259.9(20)-16.7(1)13.5(0)-16.7(;)-248.2(8)-16.7(7)13.5(:)-4.1(19)-16.7(8)13.5()-16.7(2)13.5(1)-16.7(0)13.5(.)]TJ
-1.2503 -1.1284 TD
0 Tc
[(3.)-500.4(Lym)16.4(phat)14.1(ic)-394.3(Educ)17.7(atio)14.7(n)-396.6(&)-396.2(Rese)11.5(arc)13.2(h)-396.6(Netw)10.9(ork)15.5(.)-396.5(Lymp)16.3(hede)15.4(ma)]TJ
1.2503 -1.1223 TD
[(and)-334(lym)12.8(phat)14.1(ic)-345.5(di)12.5(sea)10.3(ses)-344.4(af)11.5(fect)-340.1(mi)12.9(illi)13.9(ons)-335(and)-340.1(con)13.7(cern)-340.7(us)-341(all)14.8(.)]TJ
0 -1.1284 TD
[(Ava)12.1(ila)14.8(ble)-467.6(at:)-467(htt)12.9(ps:)13.2(//ly)13.4(mph)12.2(atic)16.6(netw)12.5(ork)15.5(.or)15.6(g.)-463.8(Acce)9.6(ssed)-460.5(Jan-)]TJ
0 -1.1223 TD
[(uar)11.3(y)-329.5(25,)-317.5(2021)17.7(.)]TJ
-1.2503 -1.1284 TD
-.0189 Tc
[(4)-18.9(.)-519.3(Nation)5.4(a)-4.9(l)-341.7(I)-3.1(n)5.4(s).1(titu)5.4(tes)-347.5(o)-.7(f)-344.6(H)3.8(eal)5.9(t)-.2(h,)-342.2(Natio)5.4(nal)-347.8(C).6(ent)5.9(e)-4.9(r)-344.6(f)3(or)-344.6(Advancin)5.4(g)]TJ
1.2503 -1.1223 TD
[(Tran)5.4(slation)5.4(a)-4.9(l)-780.9(S)-3.6(cien)5.4(ces,)-781.4(Lip)5.4(e)1.2(dema.)-787.5(A)3.8(vailable)-785.6(a)1.2(t:)-787(h)5.4(ttps)6.2(://)]TJ
0 -1.1284 TD
-.0186 Tc
[(rared)5.7(i).1(seas)6.5(es)24.8(.in)5.7(f)-2.8(o)24(.nih)24(.)-.4(g)5.7(ov/d)5.7(i).1(seases/105)5.7(42/)6.2(lipedema.)-836(Accessed)]TJ
0 -1.1223 TD
[(Jan)5.8(u)-.3(ary)-329.7(2)-.3(5)5.8(,)-335.7(2)5.8(021.)]TJ
/F3 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
0 Tc
[(CENTERS)-336.6(OF)-337.5(EXCELLENCE)-338.1(FOR)-334(LYMPHATIC)-336.9(DISEASE)-27239.9(9)]TJ
ET
endstream
endobj
57 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.2951 0 0 9.2951 66.6708 725.1588 Tm
0 0 0 rg
-.0136 Tc
0 Tw
[(5)-13.6(.)-514(Sieg)4.6(el)-263.2(RL,)-263.7(M)-.8(i)5.1(ller)-260(K)-13.6(D)13.5(,)-263.7(J)5.4(e).4(mal)-263.2(A)3(.)-263.7(C)-.2(an)-13.6(c)12.4(e)6.5(r)-266.1(s)-.7(t)5.1(a).4(tis)5.4(tics)5.4(.)-263.7(CA)-265.4(Can)4.6(cer)]TJ
1.2503 -1.1223 TD
-.0302 Tc
[(J)-346.6(C)-16.8(l)-17.6(i)-17.6(n)-347.5(2)-12(0)-30.2(20)-30.2(;)-334.9(7)-30.2(0:)-17.6(7)-12()-30.2(30)-30.2(.)]TJ
-1.2503 -1.1284 TD
0 Tc
[(6.)-500.4(Shah)-263.8(C,)-267.3(Arthur)-262.7(DW,)-268.6(Wazer)-264(D,)-264.1(Khan)-268.6(A,)-264.1(Ridner)-267.8(S,)-259.3(Vicini)-267.2(F.)]TJ
1.2503 -1.1223 TD
[(The)-451.8(impact)-452.9(of)-453.9(early)-450(detection)-457.4(and)-449.9(intervention)-455.4(of)-453.9(breast)]TJ
0 -1.1283 TD
[(cancer-related)-415.4(lymphedema:)-408.7(A)-404.3(systematic)-406.6(review.)-409.1(Cancer)]TJ
0 -1.1223 TD
[(Med)-333.3(2016;)-335.6(5:11541162.)]TJ
-1.2503 -1.1284 TD
[(7.)-500.4(Stout)-380.6(Gergich)-384.8(NL,)-388.1(Pfalzer)-386.5(LA,)-382(McGarvey)-382.9(C,)-383.1(Springer)-384.4(B,)]TJ
1.2503 -1.1223 TD
[(Gerber)-296.1(LH,)-290.5(Soballe)-291.7(P.)-289.8(Preoperative)-299.4(assessment)-296.2(enables)-292.7(the)]TJ
0 -1.1284 TD
[(early)-425.6(diagnosis)-429.5(and)-425.5(successful)-427.9(treatment)-428.8(of)-423.5(lymphedema.)]TJ
0 -1.1223 TD
[(Cancer)-337.8(2008;)-335.6(112:28092819.)]TJ
-1.2503 -1.1284 TD
.2501 Tc
[(8)250.1(.)-250.3(J)263(o)268.3(h)250.1(n)280.3(s)263(o)250.1(n)18(A)250.1(R)274(,)0(K)266.7(i)262.7(m)268.7(b)250.1(a)276.1(l)268.8(l)-5.6(S)265.4(,E)266.4(p)268.3(s)263(t)262.7(e)264.1(i)268.8(n)-.1(S)265.4(,)0(R)263.5(e)264.1(c)264.1(h)250.1(t)12.5(A)266.7(,L)266.4(i)262.7(n)-.1(S)265.4(J)263(,L)266.4(e)264.1(e)1.8(B)263.5(T)250.1(,)]TJ
1.2503 -1.1223 TD
-.0153 Tc
[(James)-337.8(T)1(A)-15.3(,)-322.1(Sing)-15.3(h)14.9(a)-1.3(l)-338.1(D)1.3(.)-332.5(L)-15.3(y)13(m)-2.8(ph)-15.3(e)10.7(d)2.9(ema)-336.8(i)3.4(n)-15.3(c)10.7(id)-15.3(e)10.7(n)2.9(ce)-336.8(after)-334.9(a)-1.3(xillar)-15.3(y)]TJ
0 -1.1284 TD
-.0133 Tc
[(ly)4.9(mp)4.9(h)-385.5(n)-13.3(o)16.9(d)-13.3(e)-371.5(d)4.9(issect)5.4(io)4.9(n)-13.3(:)-372.9(Qu)-13.3(a)12.7(n)4.9(tify)4.9(i)-.7(n)4.9(g)-385.5(th)4.9(e)-389.7(i)5.4(mp)-13.3(a)12.7(c)6.8(t)-384.9(o)-13.3(f)-369.7(r)-13.3(a)10.4(d)4.9(iat)5.4(i)-.7(o)-13.3(n)]TJ
T*
-.0154 Tc
[(an)-15.4(d)-223.1(t)-2.8(he)-239.3(lymph)-15.4(a)10.6(tic)-239.3(m)-2.9(icr)-15.4(o)12.5(surg)-15.4(i)9.3(cal)-234.5(p)-15.4(r)12.5(even)-15.4(t)9.3(i)3.3(v)-15.4(e)-227.3(healin)-15.4(g)-223.1(a)-1.4(p)-15.4(p)14.8(r)-15.4(o)12.5(ach)-15.4(.)]TJ
0 -1.1223 TD
0 Tc
[(A)16.6(n)0(n)-305.2(P)15.3(l)12.6(a)14(s)19(t)-322.8(S)15.3(u)18.2(rg)-307.6(2)18.2(0)0(1)30.2(9)0(;)-304.7(8)0(2)30.2(\()15.8(4S)-308.1(S)15.3(u)18.2(pp)30.2(l)-316.7(3)0(\))27.9(:)12.6(S)15.3(2)18.2(34)30.2(S)27.3(24)30.2(1.)]TJ
-1.2503 -1.1284 TD
.0243 Tc
[(9)24.3(.)-476.1(Bl)-5.8(ome)-772.9(C)1.1(,)-774.8(S)3(andner)-771.1(A)-1.8(,)-768.7(H)-1.8(erb)-6.3(e)1.7(rger)-777.2(K,)-774.8(August)-5.8(i).3(n)-768.7(M)-5.6(.)]TJ
1.2503 -1.1223 TD
[(Lymphedem)-5.9(a)1.7(the)-413.1(long)-415(way)-408.9(t).3(o)-415(d)-.2(iag)-6.3(nosis)-414.1(and)-408.9(t)-5.8(herap)-6.3(y)-.2(.)]TJ
0 -1.1284 TD
.0245 Tc
[(Vas)-5.2(a)-351.9(2013;)-353.2(42:363369.)]TJ
-1.7505 -1.1223 TD
0 Tc
[(10.)-500.5(Granger)-491.4(DN,)-491.5(Skeff)-488.2(KM,)-495.2(Chaite)-488.7(W,)-492.5(Rockson)-491(SG.)-486.7(Lym-)]TJ
1.7505 -1.1284 TD
[(phatic)-349.7(biology)-347.5(and)-346.2(disease:)-352.4(Is)-343.3(it)-346.8(being)-345.9(taught?)-349.8(Who)-346.3(is)-352.6(lis-)]TJ
0 -1.1223 TD
[(tening?)-337.6(Lymphatic)-333.3(Res)-337.9(Biol)-333.6(2004;)-335.6(2:8695.)]TJ
-1.7505 -1.1284 TD
-.0144 Tc
[(1)-14.4(1)-14.4(.)-514.9(Gu)-14.4(a)11.6(r)1.4(d)-14.4(a)11.6(do)-325.6(JR)5.1(.)-325.5(P).9(o)-14.4(l)16.4(icy)-325.6(r)1.4(ese)5.7(a)-.4(r)-14.4(c)9.3(h)-319.5(p)-14.4(e)11.6(r)1.4(spectives:)-325(M)4.5(ed)-14.4(i)16.4(cal)-325(liability)]TJ
1.7505 -1.1223 TD
-.0151 Tc
[(claim)-332(f)-15.1(r)10.5(e)-1.1(qu)-15.1(e)10.9(n)3.1(cy)-332.4(amon)-15.1(g)-320.3(U)1.5(.)-15.1(S)12.3(.)-332.3(p)-15.1(h)15.1(y)-15.1(s)16(i)-2.5(cians.)-332.3(20)-15.1(1)15.1(6)-15.1(.)-320.3(A)1.5(v)-15.1(a)10.9(ilab)-15.1(l)15.7(e)-336.6(at:)]TJ
0 -1.1284 TD
0 Tc
[(ht)30.8(t)12.6(p)18.2(s)12.9(:)12.6(/)18.7(/)12.6(w)16.6(w)0(w)39.3(.)18.2(a)14(m)12.5(a)14(-assn.o)-11.8(rg/sites)-10.3(/default)-10.2(/les/med)-9.6(ia-br)-9(owser/)]TJ
0 -1.1223 TD
.0118 Tc
[(pub)5.6(lic/government/advo)5.6(cacy/po)5.6(licy-research-p)5.6(erspective-)]TJ
0 -1.1284 TD
[(medical-li)11.9(a)-10.3(b)5.7(ility-cl)11.9(a)-10.3(im)11.9(-)-8.6(f)3.3(requency.)-6.5(pdf.)-543.2(A)-2(ccessed)-543.3(J).4(anuary)]TJ
0 -1.1223 TD
.0123 Tc
[(25,)-329.3(202)6.1(1.)]TJ
-1.7505 -1.1284 TD
0 Tc
[(12.)-500.5(Chang)-357.4(DW,)-360(Suami)-360.6(H,)-355.6(Skoracki)-361.9(R.)-358.8(A)-355.5(prospective)-362.2(analysis)]TJ
1.7505 -1.1223 TD
[(of)-411.3(100)-415.2(consecutive)-412.8(lymphovenous)-412.7(bypass)-412(cases)-414.1(for)-413.7(treat-)]TJ
0 -1.1284 TD
[(ment)-308.7(of)-313.7(extremity)-308.7(lymphedema.)-311.6(Plast)-310.8(Reconstr)-314.1(Surg)-310.8(2013;)]TJ
0 -1.1223 TD
(132:13051314.)Tj
25.2569 33.7593 TD
[(13.)-500.5(Dayan)-340.1(JH,)-330.4(Ly)-331.5(CL,)-336.4(Kataru)-335.9(RP,)-331.3(Mehrara)-340.8(BJ.)-333.6(Lymphedema:)]TJ
1.7505 -1.1223 TD
[(Pathogenesis)-252.2(and)-248.6(novel)-242.2(therapies.)-252.2(Annu)-246.1(Rev)-247.3(Med)-247.9(2018;)-244.1(69:)]TJ
0 -1.1284 TD
(263276.)Tj
-1.7505 -1.1223 TD
[(14.)-500.5(Schaverien)-382.8(MV,)-385.5(Coroneos)-377.5(CJ.)-382.4(Surgical)-379.6(treatment)-380.1(of)-380.8(lym-)]TJ
1.7505 -1.1283 TD
[(phedema.)-336.5(Plast)-335.2(Reconstr)-338.5(Surg)-335.1(2019;)-329.5(144:73887758.)]TJ
-1.7505 -1.1223 TD
[(15.)-500.5(Gould)-349.4(DJ,)-348.7(Mehrara)-346.9(BJ,)-345.8(Neligan)-351.4(P,)-344.7(Cheng)-345.2(MH,)-348.9(Patel)-346.3(KM.)]TJ
1.7505 -1.1284 TD
[(Lymph)-398.6(node)-401.2(transplantation)-403.7(for)-395.4(the)-400.5(treatment)-404.4(of)-399.1(lymphe-)]TJ
0 -1.1223 TD
[(dema.)-338(J)-334.7(Surg)-335.2(Oncol)-335.3(2018;)-329.5(118:736742.)]TJ
-1.7505 -1.1284 TD
[(16.)-500.5(Ehrlich)-349.8(C,)-340.5(Iker)-344.9(E,)-343.7(Herbst)-349.1(KL,)-345.4(Kahn)-341.8(L-A,)-347.9(Sears)-342.8(DD,)-345.1(Ken-)]TJ
1.7505 -1.1223 TD
[(yon)-268.8(M,)-261.7(McMahon)-270.2(E.)]TJ
/F10 1 Tf
8.728 0 TD
[(Lymphedema)-264.1(and)-268.8(Lipedema)-263.5(Nutrition)]TJ
-8.728 -1.1284 TD
(Guide)Tj
/F5 1 Tf
2.4519 0 TD
[(.)-329.4(San)-336.9(Francisco,)-334.9(CA:)-335.6(Lymph)-337.6(Notes;)-334(2016.)]TJ
-4.2024 -1.1223 TD
[(17.)-500.5(Lymphatic)-437(Education)-437.4(&)-432.7(Research)-438.9(Network.)-437.1(The)-433.5(Interna-)]TJ
1.7505 -1.1284 TD
[(tional)-424.2(Lymphatic)-418.7(Disease)-421.5(and)-419.4(Lymphedema)-417.7(Patient)-425.4(Reg-)]TJ
T*
[(istry)-665.8(&)-664.5(Biorepository.)-665.6(Available)-672.5(at:)-662.2(https://lernregistry)]TJ
0 -1.1223 TD
[(.stanford.edu.)-336.7(Accessed)-341(January)-334.1(25,)-335.8(2021.)]TJ
-1.7505 -1.1284 TD
[(18.)-500.5(Centers)-344.4(for)-346.6(Medicare)-342.3(&)-347.4(Medicaid)-341.3(Services.)-347(Physician)-346(and)]TJ
1.7505 -1.1223 TD
[(Other)-569.4(Supplier)-564.5(Data)-571.1(CY)-567.8(2012.)-561.8(Available)-568.8(at:)-570.7(c)-28.7(m)-30.2(s)]TJ
21.8231 0 TD
.0306 Tc
(.gov/)Tj
-21.8231 -1.1284 TD
.0312 Tc
[(R)-4.2(e)2.5(s)-4.7(e)2.5(arch-Statis)-4.7(tics)-4.7(-)4.3(Data-and-)]TJ
12.8816 0 TD
.0355 Tc
[(S)8.1(y)4.9(st)5.4(e)6.8(m)5.3(s/)5.4(S)8.1(t)-.7(a)6.8(t)5.4(is)5.8(t)5.4(i)5.4(c).7(-)8.6(T)3(ren)4.9(d)4.9(s)5.7(-)]TJ
-12.8816 -1.1223 TD
0 Tc
[(an)13.8(d-)21.8(Re)21.2(po)18(rt)16.3(s)12.9(/)0(M)19.3(e)0(d)19.9(i)0(c)20.5(a)0(r)17.6(e)0(-)17.6(P)0(r)18.9(o)0(v)18(i)12.6(de)19.9(r-)19.5(Ch)19.3(ar)17.6(ge)19.9(-D)20.2(at)14.4(a/)20.5(Ph)21.2(ys)18.9(ic)20.5(ia)14.4(n-)21.8(an)19.9(d-)]TJ
0 -1.1284 TD
[(Ot)17(he)19.9(r-)19.5(Su)21.2(pp)18(li)19.2(er)17.6(20)18(12)24.1(.)-323.3(A)0(c)18.3(c)0(e)15.7(s)12.9(se)14.7(d)-323.4(J)12.9(an)19.9(ua)13.8(ry)-313.7(25)24.1(,)-323.3(2)0(0)18(2)0(1)18(.)]TJ
9.843 0 0 9.843 441.014 498.0471 Tm
[(Address)-337.6(correspondence)-337.8(to:)]TJ
/F10 1 Tf
-1.4284 -1.1174 TD
[(Meliss)-8.7(a)-329.4(B)0(.)-334(Aldrich,)-336.1(MBA,)-338.5(PhD)]TJ
1.7509 -1.1116 TD
[(McGovern)-342.4(Medical)-333.9(School)]TJ
6.9692 -1.1116 TD
(UTHealth)Tj
-4.4695 -1.1174 TD
[(1825)-338.5(Pressler,)-337.7(330D)]TJ
.5011 -1.1116 TD
[(Houston,)-334.5(TX)-337.3(77030)]TJ
6.1399 -1.1116 TD
(USA)Tj
-14.0249 -2.1253 TD
(E-mail:)Tj
/F5 1 Tf
3.3982 0 TD
(melissa.b.aldrich@uth.tmc.edu)Tj
/F3 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(10)Tj
47.4471 0 TD
[(CHANG)-336.8(ET)-338.7(AL.)]TJ
ET
endstream
endobj
69 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
72 0 obj
<>stream
htWytg
1
"!@0c8ccK-ɒu-:,˧l}`9`p&! dHavf2ɖHvfۧVկ~ae߹ЮVH e,=mAI@9z^,_X>>rreBAj"1z%]捯{?7;rGd"qr#Ƌ;23^"~h(Y(a2@E|㓒~ ;G,MˏNZ#D$AP,Zoy|be85a,֫lj_:kV
XGجfpr^V+zsooW3h_`[aCNi̙o~/eT_]4MsDYLn\bns^'wC/>xi"ǻĨKSc"%,EZHqvs_ӽ.\A.?,5
Nge &3
V~m^vmD!"#8g> D3O@-//lP)[GZ{WIR,M4d_`.sƠ2ӈ..I4p=KA$
ãymcG[$DTk1ÈV(19 {1.]'.!c2M
u$ 2D&,5 >E/h%Ңw#~s'+g#V/)xϻ=tW{6 ˣ^NpE?1ke2o2bWؖ%'̈J5]WUju<N ژP@}Vho'kj;ˀyF`YUJ$"JPǃPYRfT8S¿>B[O}L {Ub
U)snc
!;"?4F`χ`G
N65"tZUO=f$L@LNM=ɼI([ҺD2p
}3'iy-#_#x
ȱ0 ^oh&XA*Άs@̏`#Өx6[evB5t'ZT9V};7S^iD&X++#xKQm\2
'=նal>N(
rRf+WU:5h*w!5
dvc*T?0R6ˠzTtLX-DDXiYgF]
eLfZU$,VTsk<
SIy"Q::",CgOo`E[5*Vc6HE;Ŕ8[X|Dd/`_'>k:zI7G`Bf>02H'N' yۮ`:ůhr#֚KC{X?pB]p{
{믻,.Dx{+ϫξ{Zň搡aUszɝV}=xG >Y(Dj4'qX-'ΰ$ه H۳WzcVf:A!]j9IM7xjEgwH2p$B-`ذlz6%x4ڨ)oz
_\